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1.1. Introduction to Karanj (Derris Indica) 
 
Karanj tree is a wonderful tree almost like neem tree. 
 
Derris indica (Lamk.) Bennet  
Family: Fabaceae 
Local Name: Karanj 
  
Species identity (1, 2) 
 
Taxonomy:   
Current name: Pongamia pinnata  
Family: Fabaceae - Papilionoideae 
Synonym(s):   
Derris indica (Lam.) Bennett  
Millettia novo-guineensis Kane. & Hat.  
Pongamia glabra Vent.  
Pongamia pinnata Merr. 
 
Common names: 
 
(Arabic) : um al shuur 
(Bengali) : karanj, karanja, s[aa]m hoa 
(Cantonese) : honge 
(English) : Indian beech, karum tree, oil tree, pongam, pongam oil 
tree, poonga-oil-tree, seashore mempari 
(Filipino) : báni 
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(French) : arbre de pongolote 
(Hindi) : kanji, karanj, karanja, papar 
(Indonesian) : bangkong, biansu, ki pahang laut, kranji, melapari 
(Javanese) : bangkong 
(Lao (Sino-Tibetan)) : (do:k) ko:m ko:y, dok kom koi 
(Malay) : biansu, kacang kayu laut, malapari, mempare, mempari, 
pari-pari, pongu 
(Nepali) : karanji, karauini 
(Sanskrit) : karanj, karanja 
(Sinhala) : karanda, kona 
(Tamil) : dalkaramcha, ponga, pongam, pungam, punku 
(Thai) : khayi, ko:m ko:y, yi-nam 
(Trade name) : karanga, pongam 
(Vietnamese) : d[aa]y kim, d[aa]y m[aas]u, day lim, day mau, 
kh[oor], kh[oor]s[aa]m hoa, s[aa]m hoa 
 
1.2. Botanic description (3) 
 
Pongamia pinnata is a medium-sized evergreen or briefly 
deciduous, glabrous shrub or tree 15-25 m high, with straight or crooked 
trunk 50-80 cm or more in diameter and broad crown of spreading or 
drooping branches. Bark is grey-brown, smooth or faintly vertically 
fissured. Branchlets are hairless with pale stipule scars. Leaves are 
alternate, imparipinnate with long slender leafstalk, hairless, pinkish-red 
when young, glossy dark green above and dull green with prominent 
veins beneath when mature. Leaflets are 5-9, paired except at end, short-
stalked, ovate elliptical or oblong, obtuse-acuminate at apex, rounded to 
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cuneate at base, not toothed at the edges, slightly thickened. Inflorescence 
is raceme-like, axillary, 6-27 cm long, bearing pairs of strongly fragrant 
flowers; calyx campanulate, 4-5 mm long, truncate, finely pubescent. 
Flower clusters at base of and shorter than leaves, to 15 cm long, slender, 
drooping. Flowers are 2-4 together, short-stalked, pea-shaped, 15-18 mm 
long. Calyx is campanulate, 4-5 mm long, truncate, finely pubescent; 
corolla white to pink, purple inside, brownish veined outside, 5-toothed, 
standard rounded obovate 1-2 cm long, with basal auricles, often with 
green central blotch and thin silky hairs on back; wings oblong, oblique, 
slightly adherent to obtuse keel.  
 
Figure 1.1: A 10-year old Pongamia pinnata tree 
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Pods borne in quantities, smooth, oblique oblong to ellipsoid, 
flattened but slightly swollen, slightly curved with short, curved point 
(beaked), brown, thick-walled, thick leathery to subwoody, hard, 
indehiscent, 1-2 seeded, short stalked. Seeds are compressed ovoid or 
elliptical, bean-like with a brittle coat long, flattened, dark brown, oily.  
 
This species has been placed alone in its genus Pongamia, derived 
from the Malabar local name (pongam). In 1972, S. R. Bennet, an Indian 
taxonomist gave the pongam a new name, Derris indica (Lamk.) Bennet, 
but this change has not been generally adopted. The name Derris, derived 
from Greek, means ‘leather covering or skin’; the specific name ‘indica’ 
obviously means of India. 
 
History of cultivation (4) 
 
Pongamia pinnata is originated from India and occurs naturally and 
is naturalized from Pakistan, India and Sri Lanka throughout south-east 
Asia to north-eastern Australia, Fiji and Japan. It is planted in the humid 
tropical lowlands around the world, and has been introduced in Egypt and 
the United States. 
 
Natural Habitat: P. pinnata is native to humid and sub-tropic 
environments; common along waterways or seashores, with its roots in 
fresh or saltwater. It is very tolerant of saline conditions and alkalinity, 
and occurs naturally in lowland forest on limestone and rocky coral 
outcrops on the coast, along the edges of mangrove forest and along tidal 
streams and rivers. It is a shade bearer and can grow under the shade of 
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other trees; it is, however, not a shade demander and grows well even 
with full overhead light. It is also drought resistant and well adapted to 
adverse climatic conditions and soil moisture conditions; prolonged 
drought may however kill seedlings. In its natural habitat, the species 
tolerates a wide temperature range. Mature trees withstand light frost, 
water logging and tolerate temperatures of up to 50°C. In addition to rain, 
trees require a dry season of 2-6 months. 
 
Geographic distribution:  
Native: Bangladesh, India, Myanmar, Nepal, Thailand. 
Exotic : Australia, China, Egypt, Fiji, Indonesia, Japan, Malaysia, 
Mauritius, New Zealand, Pakistan, Papua New Guinea, Philippines, 
Samoa, Seychelles, Solomon Islands, Sri Lanka, Sudan, Tonga, United 
States of America. 
Biophysical limits: Altitude: 0-1 200 m, Mean annual temperature: 1-16 
to 27-50°C, Mean annual rainfall: 500-2 500 mm, Soil type: P. pinnata 
can grow on most soil types; best growth is found on deep well-drained 
sandy loams with assured moisture, but it grows on sandy soils and heavy 
swelling clay soils. It does not do well on dry sands, although it tolerates 
saline conditions, alkalinity and waterlogged soils. 
Reproductive Biology: In Florida, it sheds its leaves in April and 
develops new leaves and flowers from May onwards. In India, seed 
ripens from February to May. Pod production starts 5-7 years after 
sowing. They do not open naturally, and must decay before seeds can 
germinate. 
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Propagation methods: Natural reproduction is profuse by seed and 
common by root suckers. Spontaneous seedlings and root suckers are 
produced and may cause serious weed problems. Direct sowing is 
common and most successful. Seeds require no pre-treatment and 
germinate within 7 days to 1 month of sowing. Germination is hypogeal 
and the radicle develops quickly before the plumule emerges. In the 
nursery, it can be planted at a close spacing, as young plants tolerate 
shade well; in India a spacing of 7.5 x 15 cm is recommended. Seedlings 
attain a height of 25-30 cm in their first growing season. Transplanting to 
the field should occur at the beginning of the next rainy season when 
seedlings are about 60 cm in height. Seedlings have large root systems 
and soil should be retained around the roots during transplanting. Easily 
established by direct seeding or by planting nursery-raised seedlings or 
stump cuttings of 1-2 cm root-collar diameter. Propagation by branch 
cuttings and root suckers is also possible. 
Tree Management: Seedling survival and growth benefit from annual 
weed control for the first 3 years after transplanting. Growth of young 
trees is fairly slow. Trees coppice well and can also be pollarded. When 
planted as a shade or ornamental tree, pruning may be necessary to obtain 
a trunk of appropriate height. The spacing adopted in avenue planting is 
about 8 m between plants. In block plantings, the spacing can range from 
2 x 2 m to 5 x 5 m. The lateral spread of roots on this species, about 9 m 
in 18 years, is greater than most other species; moreover it produces root 
suckers profusely. Because of these characteristics, pongam is unsuitable 
for agroforestry and has the potential to become a weed if not managed 
carefully. Individual trees yield 9-90 kg of pods annually, while mature 
trees yield 8-24 kg of seeds annually. 
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Germplasm Management: Seed storage behaviour is orthodox and seeds 
remain viable for about a year when stored in air-tight containers. There 
are 1 500-1 700 seeds/kg. 
 
1.3. Functional uses (5-7) 
 
 
Figure 1.2: The pongamia nursery become a new income-generating 
activity in the village 
 
Products: Karanja tree is wonderful tree almost like neem tree. 
Fodder: The leaves can be eaten by cattle and are readily consumed by 
goats however it is not common. The leaves contain 43% dry matter, 18% 
crude protein, 62% neutral detergent fibre, and in vitro dry matter 
digestibility of 50%. The press cake (seed residue) after oil extraction is 
bitter and unfit for use as a sole animal feed. It is high in protein, but 
posses several toxic flavonoids including 1.25% karanjin, and 0.85% 
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pongamol alkaloid, resin, mucilage, sugar and tannin. These toxins are oil 
soluble and most of the toxins are removed during solvent extraction of 
oil from cake with hexane.  The de-oiled cakes could be used in 
compound cattle feed. It is suggested as a short-term substitute for other 
protein sources but never serving as more than a 75% replacement. The 
cake contains nitrogen (N) 5.1%, phosphorous (P 2 O 5) 1.1% and potash 
(K 2  0) 1.3.% and has been reported as a useful organic manure for 
sugarcane, coffee, oranges, and paddy.  It repeals red ants and also 
reported effective for nematode controls. It also possesses nitrification 
inhibition property and cake is used in blending with nitrogenous 
fertilizers.  
Apiculture: P. pinnata flowers are considered a good source of pollen for 
honeybees in India and they yield adequate nectar.  
Fuel: With a calorific value of 4 600 kcal/kg, it is commonly used as a 
fuel wood. The seed oil was formerly indispensable as an illuminant in 
lamps, but has been largely replaced by kerosene.  
Timber: Wood varies from white to yellowish-grey with no distinct 
heartwood; beautifully grained and medium to coarse textured. Although 
it is a moderately strong timber that is relatively easy to saw, turn and 
finish, the wood is not considered a quality timber because it is not 
durable, tends to split and warp during seasoning and is susceptible to 
insect attack. The wood is used for cabinet making, cartwheels, posts, 
agricultural implements, tool handles and combs.  
Tannin or dyestuff: Roots yield a natural pigment, pinnatin, which was 
synthesized in 1967. The wood ash is employed in dyeing. Oil from the 
seeds is used for leather dressing in tanning industries.  
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Lipids: Oil is the most important product of the pongam tree and vast 
amounts of seeds are collected in India for commercial processing of 
industrial uses. It has been found that the seed contains 27-40% of thick, 
yellow or reddish-brown oil and that 2 kg of mature pods will yield about 
1 kg of husked kernels. Extracted oil amounts to 13.4% of the whole seed 
pod; 26.97% of the kernels. The oil has a bitter taste, a disagreeable 
aroma and a specific gravity of 0.9371 at 15 deg. C. It is used as a 
lubricant, varnish, water-paint binder and in soap making. It is one of the 
few nitrogen-fixing trees to produce seeds containing oil.  
Poison: The press cake, when applied to the soil is valued as a pesticide, 
particularly against nematodes. In rural areas, dried leaves are stored with 
grain to repel insects. Pounded and roasted seeds used to be utilized as 
fish poison.  
 
Medicine: The seed oil is rubbed as liniment on skin diseases and 
rheumatic parts. Internally, it is given as a stomachic and cholagogue in 
dyspepsia and cases of sluggish liver. A seed powder is given as an 
expectorant in bronchitis and whooping cough, and is also prescribed as a 
ferbifuge and tonic. Seed paste is spread on sores and rheumatic parts. An 
infusion of the leaves is used to relieve rheumatism, a decoction is a 
cough remedy, expressed juice is used on herpes and itches, and when 
they are crushed, applied as a poultice for the treatment of parasitic skin 
diseases. The flowers are claimed to have anti-diabetic action. Fresh stem 
bark is applied to reduce the enlargement of the spleen. It is astringent 
and taken internally to relieve bleeding heamorrhoids while a poultice of 
young leaves is laid on externally. The root bark contains a bitter alkaloid 
and is employed by the people of Guimaras Island in the Philippines as an 
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abortifacient. The antiseptic root juice is put on sores and ulcers and used 
to clean teeth. Other products: In India, the tree is a host for the useful lac 
insect. It is also used as a host for the hemiparasitic sandalwood, 
Santalum album L. 
 
According to Ayurveda, Karanj is anthelmintic, alexipharmic and 
useful in diseases of eye, vagina, skin. It is good for tumour, wounds, 
ulcers, itching, ascites, enlargement of spleen and abdomen, urinary 
discharges. It also cures biliousness, piles, head pains, leucoderma, skin 
diseases and wounds. According to Unani system of medicine, seeds are 
acrid and carminative, purify and enrich blood, relieves inflammations, 
cure earache, chest complaints, lumbago, chronic fever and hydrocele. 
Oil is styptic and anthelmintic. It is good in scabies, leprosy, piles, 
lumbago, chronic fever, liver pain etc. 
 
The natives and traditional healers of Chhattisgarh use different 
parts of Karanj as medicine very frequently. In case of joint pains, they 
use Karanj roots and barks externally. These parts are powdered and with 
the help of water, aqueous paste is prepared. This paste is applied 
externally on painful joints. According to them, the roots are more 
effective as compared to barks. In order to stop, the vomiting, the natives 
use the roasted seeds of Karanj internally. It is used under supervision of 
traditional healers because overdose can create problems. The healers 
suggest the patients to take the pieces of seeds in place of whole seeds. 
To check intense pain of hydrocele, the traditional healers of Chhattisgarh 
Plains use Karanj in many ways. They apply the aqueous paste of Karanj, 
seeds externally on hydrocele for quick relief. They also use the aqueous 
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paste prepared from Karanj roots by mixing it in rice water. They prefer 
the second combination, as its use is safe as well as effective. The seed oil 
possess valuable medicinal properties, the natives use the oil externally in 
treatment of skin troubles. They add one or more herbal oils or herbs in 
this oil, in order to make it more effective. Although during field works, 
there is less chance of poisonous bites due to rats, but in such cases the 
field workers immediately apply the aqueous paste prepared by mixing 
equal quantity of Karanj bark and seeds in affected parts. The healers 
always keep the seeds with them for its use in off-seasons. The traditional 
healers specialized in treatment of liver related troubles, use different 
parts of Karanj as medicine, alone or in combination with other herbs. 
They suggest the patients to take fresh juice of bark or take bark powder 
with water. It is considered as good liver tonic. In treatment of Leprosy 
and leucoderma, the traditional healers of Pendra region, use aqueous 
paste of bark and seed oil externally as treatment. The traditional healer 
of Mudpar village uses the poultice of Karanj, Neem, and Nirgundi 
(Vitex negundo) leaves, to destroy the harmful worms present in wounds. 
It is frequently used as veterinary medicine. In treatment of Adhasisi 
(Migraine), the healer suggested the patients to burn the seeds and inhale 
the fumes during attack, for quick and long lasting relief. The problem of 
Filaria is increasing in Chhattisgarh, the traditional healers specialized in 
treatment of filaria, suggested the patients to take fresh juice of leaves 
daily as it acts as both preventive and curative. There is a need for 
dissemination of this knowledge in Chhattisgarh in order to check, the 
further spread of this problematic disease. The traditional healers of 
Narharpur region use the flower buds of Karanj in treatment of acidity.  
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The patients roast the buds in ghee and take it internally after 
lunch. This intake induces vomiting and after one or two vomiting, the 
patients get complete relief from acidity. The use of Karanj seeds in 
treatment of Jalodari is already described in previous article on Jalodari. 
Karanj is a boon for the patients having the problem of Bavasir (Piles). It 
is used both internally and externally. Internally, the leaves are roasted in 
ghee and given with whey (Mattha). Externally, the leaves and seeds are 
burnt, the patients are suggested to expose the piles in fumes. The healers 
claim that both treatments, if taken simultaneously, can root out the 
problem of piles within no time. The traditional healers of other parts of 
Chhattisgarh are also aware of this use. The traditional healers of 
Chhattisgarh Plains, advise the patient to apply aqueous paste of Karanj 
leaves externally on piles. The healers of Janjgir region, prepare a herbal 
combination using Karanj seeds and use it very commonly in treatment of 
stomach ache. According to them this combination is capable of checking 
the pain in most of the cases. The healers of Nagri - Sihawa region, 
specialized in treatment of fevers, use the leaves of Karanj with Kali 
Mirch (Black Pipper). But as other promising alternatives are available, 
they use this combination less frequently. The presence of Karanj in the 
surrounding is must, in order to live safe and healthy life. 
 
The main use of Karanja oil is in the tanning industry for dressing 
of E.I. leathers. The Karanja oil is mainly used as a raw material for 
manufacturing of washing soaps, candles and for illumination purposes.  
The main constraints for usage of karnanja oil in soaps are its colour and 
odour. Oleic acid is the principal unsaturated fatty acid averaging 45 to 
70% of all the commercially available oils from Tree Borne Oil Seeds 
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like Neem and Sal, Karanja containing maximum oleic acid, is a valuable 
raw material for oleic acid derived oleo chemicals apart from other 
traditional uses.  
 
The karanj based products exhibited outstanding antifungal activity 
against the soil-borne phytophagous fungus Sclerotium rolfsii (Sacc.). 
Karanj oil in the karanjin was more active than karanj oil without 
karanjin. Karanjin, however, exhibited moderate antifungal activity. 
Karanjic acid and their three esters exhibited significant antifungal 
activity. Karanjic acid showed the highest antifungal activity (EC50 
52.97 ppm) followed by chloroacetyl ester (EC50 50.19 ppm). Karanj 
ketone and its oxime derivaties also exhibited outstanding antifungal 
activity. The activity was enhanced when karanj ketone was converted to 
its oxime derivatives (8). 
 
Pongamia pinnata is a leguminous tree i.e. nitrogen fixing (NFTS) 
which produces seeds containing 30-40% oil. It is often planted as an 
ornamental and shade tree. This species is commonly called pongam, 
karanja, or a derivation of these names. 'Pongamia' name is derived from 
Tamil name of the plant viz. ' pongam' or ‘ pungam'. In latin “ pinnata' 
means 'feathered' and glabra’ means without hairs. It is found to grow in 
areas with annual rainfall ranging from 500 mm to over 2500 mm. It is 
drought resistant. It occurs in a wide range of soil conditions, sandy and 
saline, clayey soils, alkaline soils, but it does not grow well on very dry 
sand. Best growth has been observed on deep sandy loams with abundant 
moisture. It can occur in areas with poor as well as good drainage. It does 
well with full overhead light in its early stages. Natural reproduction is 
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profuse by seed and common by root suckers. Bark is thick grey mottled 
with brown dull yellow inside. It is indigenous through out India from 
Himalayan foot-hills to Kanyakumari. Fruits have a viability period of 
one year with a germination percent of 60-80% and seed number varies 
between 810- 1410 per kilogram. Seed of karanj yields an average of 25-
30% of yellowish brown oil. It is a leguminous tree yielding nonedible oil 
which can be used as biodiesel i.e. substitute of diesel to run engine at the 
same efficiency. Traditionally, it has been used to burn household oil 
lamps and for curing skin diseases (9). The authors described various uses 
as shown in Figure 3. 
 
Figure 1.3: Usage of Pongamia pinnata 
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Warm oil of Karanj is applied on affected parts, thrice a day for 2 
weeks, for curing skin diseases. In case of toothache, plant twig is used as 
toothbrush, twice a day for one month. Oil is applied before hair wash 
once a week for two months for long or black hair. During chest pain, 
warm oil is massaged on the chest twice a day for 2 weeks (10). 
 
Karanj has nutritive value of major dry season feed resources 
available for Goats in Bhilwara and Udaipur Districts. Leaves are used as 
fodder. The composition (% dry basis) is CP (Crude protein) 10 to 13, 
NDF (neutral detergent fibre) 35 to 41, ash 6, EE (ether extract) 3 to 5, 
lignin 11, TP (Total Phenols) 3.  It has medium to high fermentability, 
and it appeared to be very deficient in fermentable protein, but may be a 
source of by-pass protein (11).  
 
T.L.C. of Alcoholic extract of the karanj bark powder on silica gel 
'G' plate using Toluene: Ethyl acetate (9:1) shows under UV light (366 
nm.) eleven fluorescent zones at Rf. 0.04 (blue), 0.08 (greenish blue), 
0.13(sky blue) 0.18 (blue) 0.25 (sky blue), 0.31 (sky blue), 0.37 (greenish 
yellow), 0.42 (sky blue), 0.47 (greenish yellow), 0.51 (light blue), 0.80 
(light blue). On exposure to iodine vapours nine spots appear at Rf. 0.09, 
0.18, 0.31, 0.37, 0.47, 0.47, 0.51, 0.80 and 0.98 (all yellow). The 
constituents are Ponganone I to XI, flavones, kanugin and demethoxy 
kanugin (12). 
 
Pongam is a fast-growing evergreen tree which reaches 40 feet in 
height and spread, forming a broad, spreading canopy casting moderate 
shade. The three-inch-long, pinnately compound, glossy green leaves are 
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briefly deciduous, dropping for just a short period of time in early spring 
but being quickly replaced by new growth. In spring, Pongam is at its 
finest when the showy, hanging clusters of white, pink, or lavender, pea-
like, fragrant blossoms appear, the clusters up to 10 inches long. These 
beautiful blossoms and the glossy, nearly-evergreen leaves help make 
Pongam a favorite for use as a specimen, shade, or windbreak. It has also 
been planted as a street tree, but dropping pods often litter the ground. 
However, the seeds which are contained within the oval, 1.5- inch-long, 
brown seedpods are poisonous, a fact which should be considered in 
placing the tree in the landscape, if many children are present (13). 
 
Physico-chemical properties of crude oil established suitability of 
P. pinnata for its use as a potential biofuel crop. The total mono 
unsaturated fatty acid (oleic acid 46%) present in seed oil was more in 
comparison to polyunsaturated fatty acid (33%) as analyzed by GC–MS. 
Seed oil also showed inhibition against the tested fungal and bacterial 
cultures. However, the efficacy of antimicrobial activity of the seed oil at 
four concentration levels (50%, 80%, 90% and 100%) against various 
pathogenic indicators was found to be concentration-dependent. The 
obtained results confirmed the use of seed oil from well characterized 
elite genotype of Pongamia as diesel fuel and in pharmaceuticals (14). 
 
Karanj is a small to medium-sized deciduous or nearly evergreen 
tree reaching 8-15 m in height, with a straight or crooked trunk 50-70 cm 
in diameter and a broad crown of spreading or drooping branches. The 
wood is used for cabinetwork, cart wheels, posts, and fuel. Bark fiber can 
be made into rope. The oil extracted from the seeds is used as a lubricant, 
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fuel, leather dressing, and in the manufacture of soaps, varnish, paints and 
medicine. Seed residue has insecticidal and pesticidal properties; it can be 
served to poultry or used as fertilizer. The leaves can be browsed, used as 
fodder or plowed under as green manure. Leaves, flowers, bark, seeds, 
and sap has medicinal properties. The tree is planted for erosion control, 
for afforestation in drier areas, as hedges and as ornamentals. It is 
mentioned as a possible agroforestry species. The growing period is 
perennial. The common names include as Papar, Kanji, Karanja, Karanj, 
Honge, Ponga, Pongam, Kanga, Thinwin, Oil tree, Kona, Pari-pari, 
Karanda, Pongamia, Ponga oil tree, Karum tree, Dona, Kuro-yona zoku, 
Bani, Melapari, Langi poka. It often reaches an adult height of 8 m within 
4 or 5 years. It is indigenous to the Indian subcontinent. It can be found at 
elevations between sea level and 1200 m. The tree is drought resistant. 
Because of its spontaneous seedlings and root suckers it may run wild and 
create serious weed problems (15). 
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1.4. Specification for Karanj Oil: (6) 
 
S.N. Parameter Result 
1. Karanjan Content min 20,000 ppm 
2. Specific Gravity 0.925 - 0.940 
3. Refractive Index 1.4734 - 1.4790 
4. Acid Value 20 
5. Saponification Value 186 - 196 
6. Iodine Value 80 - 90 
7. Unsaponificable Matter 3.0 
8. Organic Matter 80 - 90% 
9. Fatty acid composition % 
 - Palmitic Acid 3.7 - 7.9 
 - Stearic Acid 2.4 - 8.9 
 - Arachidic Acid 2.2 - 4.7 
 - Behanic Acid 4.2 - 5.3 
 - Lignoceric Acid 1.1 - 3.5 
 - Oleic Acid 44.5 - 71.3 
 - Linoleic Acid 10.8 - 18.3 
 - Eicosenoic Acid 9.5 - 12.4 
 
Karanj tree seems wonderful tree almost like neem tree. The oil has 
been used to treat tumours, wounds, ulcers, itching, enlargement of spleen 
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and abdomen, urinary discharges. It is also used to cure biliousness, piles, 
head pains, leucoderma, skin diseases and wounds. 
 
It is used in Ayuvedic and Siddha traditional medicine systems to 
treat various skin conditions from eczema and psoriasis to leprosy, and 
for skin protection, as it is believed to enhance the UV absorbing 
properties of conventional sunscreens. A paste made of Karanj and lime 
is used to relieve rheumatic pain, and Karanj infused baths are used for 
cleaning skin ulcers and sores. Pharmaceutical preparations based on 
Karanj Oil are used for treating skin diseases including acne, herpes, 
rosacia and leucoderma (partial or total loss of skin pigmentation, often 
occurring in patches, also known as vitiligo). Roots of the tree are used 
for cleaning gums, teeth, and ulcers. Bark is used internally for bleeding 
piles. Juices from the plant, as well as the oil, are antiseptic. 
 
According to Ayurveda, Karanj is anthelmintic, alexipharmic and 
useful in diseases of eye, vagina, skin. It is good for tumour, wounds, 
ulcers, itching, ascites, enlargement of spleen and abdomen, urinary 
discharges. It also cures biliousness, piles, head pains, leucoderma, skin 
diseases and wounds. According to Unani system of medicine, seeds are 
acrid and carminative, seeds purify and enrich blood, relieves 
inflammations, cure earache, chest complaints, lumbago, chronic fever 
and hydrocele. Oil is styptic and anthelmintic. It is good in scabies, 
leprosy, piles, lumbago, chronic fever, liver pain etc. 
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1.5. Objectives 
 
The local name of the oil of Derris Indica is Karanj oil. Medicated 
karanj oil is used widely by Vaidraj in rural areas of Gujarat for the 
treatment of rheumatism and curing skin infections. It is used for healing, 
antiseptic, and haemostatic effect externally by Vaidraj.  
 
To the best of our knowledge, no systemic information is available 
on the efficacy of karanj oil. The present investigation was aimed to study 
systematically and scientifically the efficiency of Karanj oil. The efficacy 
of Karanj oil formulations was compared with karanj oil and medicated 
karanj oil. The formulations of the oil were prepared using 
pharmaceutical methodology. The activity of the selected formulated 
product was studied for wound healing, antibacterial, and haemostatic 
efficiency. 
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2.1. Introduction to Karanj (Derris Indica) 
 
 Acharya and Raj (1) reported that the botanical research on 
medicinal plants is getting much importance and it is included among the 
advanced research in India during the recent years. Plants have much 
relevance on Socio-economic, Socio-religious aspects of human life in 
India. They described various medicinal plants with their uses. They 
described that the use of karanj Seed oil is good for curing skin 
infections. 
 
Pankaj Oudhia (2) reported that the reference literatures related to 
different systems of medicine in India specially related to Ayurveda are 
full of miraculous therapeutic properties of Karanj. He is astonished then 
why we are ignoring this useful tree?  He reported that the karanj is better 
than Jatropha. 
 
Mondal and Islam (3) investigated on the toxicity study of Derris 
indica, which belongs to family Fabaceae, and is inhabitants of India, 
Srilanka, Malaysia, North Australia and Polynesia, occurs in the tidal 
forests, river and canal banks, along the water edge in all districts in 
Bangladesh. It is a medicinal plant. The dried flowers are used in 
decoction to quench thirst in diabetes. Extracts of the leaves were active 
against Micrococcus pyogenes Var. aureus. The juice of the leaves is 
prescribed in flatulence dyspepsia, diarrhoea and cough. They have 
mentioned karanjin or pongapin, kanugin and dimethoxy kanugin, 
pongamol, etc. to be present in the seeds of the test plant D. indica. 
 
 
 
 
                                                                                                  Review of Literature 
 
                                                                                                                                 30 
Shailja Vohra (4) isolated chemical compound using methanolic 
extract of Pongamia glabra and analysed for its karanjin and other 
flavonoid and hydrocarbon content by electrospray ionisation (ESI) mass 
spectroscopy. It showed the presence of six flavonoids namely karanjin, 
desmethoxykanugin, pongachalcone, pongapin, glabrachromene I, 
glabrachromene II and six hydrocarbons namely octadecane, undecane, 
decane, octane, undecanol and tetradecanol. The karanj based products 
exhibited outstanding antifungal activity against the soil-borne 
phytophagous fungus Sclerotium rolfsii (Sacc.). Karanj oil in the karanjin 
was more active than karanj oil without karanjin. Karanjin, however, 
exhibited moderate antifungal activity. Karanjic acid and their three esters 
exhibited significant antifungal activity. Karanjic acid showed the highest 
antifungal activity. 
 
Manigauha and Patel (5) investigated the anticonvulsant effect of 
the leaf extract of Pongamia pinnata using pentylene tetrazole induced 
convulsion (PTZ) in rats. Pongamia pinnata is an indigenous plant 
belonging to the family Fabaceae (Papilionaceae) commonly known as 
Karanj. Freshly powdered leaves were extracted with 70% ethanol. The 
convulsion is induced by administration of pentylene tetrazole (80 mg/kg, 
i.p.) to wistar albino rats and those showing response were divided into 
three groups of six animals each. The group I treated with 1% normal 
saline (1ml/100gm, orally), Groups II treated with phenytoin sodium (25 
mg/kg, i.p.) and Groups III treated with ethanolic extract of PPLE at a 
dose of (250 mg/kg, i.p.). The ethanolic extract showed significant 
anticonvulsant activity by lowering the duration of extension phase (3.72 
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± 0.65) when compared to control group (8.94 ± 0.42). They concluded 
that Pongamia pinnata had significant anticonvulsant activity. 
 
Badole and Bodhankar (6) studied the antihyperglycemic activity 
of alcohol extract of Pongamia pinnata (PPSBAE) stem bark. Based on 
acute oral toxicity data, PPSBAE showed no mortality in normal mice up 
to 5,000 mg/kg. PPSBAE was administered as three doses (i.e., 100, 200, 
and 400 mg/kg) to diabetic mice, and the serum glucose level and body 
weight were measured. The onset of serum glucose reduction was 
observed at 2 h (130.32 mg/dl), peak at 4 h (151.79 mg/dl) and sustained 
at 6 h, but waned at 24 h. In the subacute study, maximum reduction 
(305.72 mg/dl) in serum glucose was observed at a dose of 400 mg/kg on 
day 28. An oral glucose tolerance test (OGTT) was carried out after 
administration PPSBAE (200 mg/kg) in non-diabetic mice previously 
loaded with 2.5 g/kg, per oral of glucose. The PPSBAE (200 mg/kg) 
showed increased glucose threshold in non-diabetic mice. It was found 
that the PPSBAE possesses antihyperglycemic activity. 
 
Musthafa et.at. (7) investigated the effects of Pongamia pinnata, an 
indigenous plant used in Ayurvedic Medicine in India on the temporal 
variations of circulatory lipid peroxidation products and antioxidants in 
ammonium chloride-(AC)-induced hyperammonemic rats. Experimental 
rats were divided into control, AC-treated, those treated with AC + 
ethanolic leaf extract of P. pinnata (PPEt), and PPEt-treated. The 
characteristics of 24 h rhythms (acrophase, amplitude and mesor) of lipid 
peroxidation products (thiobarbituric acid reactive substances – TBARS) 
and antioxidants (reduced glutathione (GSH), glutathione peroxidase 
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(GPx), superoxide dismutase (SOD) and catalase (CAT)) were analyzed. 
Elevated lipid peroxidation (increased mesor of TBARS) associated with 
decreased activities of antioxidants (decreased mesor of GPx, GSH, SOD 
and CAT) were found in hyperammonemic rats. Differences were also 
found in amplitude and ‘r’ values between the hyperammonemic rats and 
other experimental groups. These alterations clearly indicate that 
temporal redox status could be modulated by PPEt during 
hyperammonemic conditions, which may also play a crucial role in 
disease development. 
 
Swaminathan et. al. (8) studied the improved seed germination of 
Derris indica by vertical sowing. Seeds of Derris indica were sown by 
five different methods. Sowing the seeds vertically with the micropyle 
directed downwards gave the maximum germination of 92%. Vertical 
sowing with the micropyle oriented laterally and upwards recorded 
respectively germinability of 58 and 66%. Sowing the seeds flat gave 
germination of 72% indicating that micropyle orientation is more 
important than disposition of seed vertically or flat. Parameters like 
germination energy, germination value and emergence energy value were 
also high when seeds were sown vertically with the micropyle pointed 
downwards. The plausible reason for this is discussed. The study has 
failed to sustain the contention that germination is positively correlated 
with seed soil contact area. The study also indicated that presowing 
treatment with water is not necessary for maximising germination for this 
species. 
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Prakash et. al. (9) investigated on the production of biodiesel 
through transesterification of Karanja (Pongamia pinnata) oil was studied. 
The Karanja oil was treated with a lower alcohol (methanol) in the 
presence of a base catalyst (KOH) to yield methyl esters of fatty acids 
(biodiesel) and glycerin. The influences of reaction temperature, molar 
ratio of alcohol to oil, amount of catalyst and reaction time on the product 
yield were studied. The optimal combination of operating parameters for 
maximum yield was found out using Taguchi’s method. The performance 
and emission tests were carried out in a four stroke single cylinder, 
Kirloskar AV1 D.I.Engine. Different blends of biodiesel with 
conventional diesel were tested. The results show an appreciable 
reduction in emission level and marginal increase in performance when 
compared with sole fuel. The results concluded that the biodiesel from 
Karanja oil can be used as an effective alternate in existing diesel engines 
without any engine hardware modifications. 
 
Chopade et. al. (10) reviewed on the Phytochemical constituents, 
Traditional uses and Pharmacological properties of Pongamia pinnata. 
Many herbal remedies individually or in combination have been 
recommended in various medical treatises for the cure of different 
diseases. The Pongamia pinnata, commonly known as ‘Karanj’, has been 
recognized in different system of traditional medicines for the treatment 
of diff erent diseases and ailments of human beings. It contains several 
phytoconstituents belonging to category fl avonoids and fixed oils. The 
fruits and sprouts of P. pinnata were used in folk remedies for abdominal 
tumours in India, the seeds for keloid tumours in Sri Lanka and a powder 
derived from the plant for tumours in Vietnam. In Sanskritic India, seeds 
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were used for skin aliments. Today, the oil is used as a liniment for 
rheumatism. Leaves are active against Micrococcus; their juice is used for 
cold, cough, diarrhoea, dyspepsia, fl atulence, gonorrhoea and leprosy. 
Roots are used for cleaning gums, teeth and ulcers. Bark is used internally 
for bleeding piles. Juices from the plant as well as oil are antiseptic. In the 
traditional systems of medicines, such as Ayurveda and Unani, the P. 
pinnata plant is used for anti-infl ammatory, anti-plasmodial, anti-
nonciceptive, anti-hyperglycaemics, anti-lipidoxidative, anti-diarrhoeal, 
anti-ulcer, anti-hyperammonic and antioxidant. Its oil is a source of 
biodiesel. It has also alternative source of energy, which is renewable, 
safe and non-pollutant. 
 
Meher et. al. (11) studied the transesterification of Pongamia 
pinnata oil by means of methanol to study the feasibility of methanolysis 
process by using potassium hydroxide catalysts. The yield of biodiesel 
obtained was >97 per cent by using oil/methanol molar ratio 12:1, 
potassium hydroxide as catalyst, at 65oC and stirring at 360 rpm in 3 h. 
The biodiesel was characterized by TLC and HPLC analysis to determine 
the fatty acid methyl esters, mono-, di- and triglycerides and glycerol. 
The properties like viscosity, flash point, cloud point, and pour point have 
been determined for accessing the fuel quality of karanja based biodiesel. 
 
Naghmana Rashid et. al. (12) isolated Karanjachromene, 
C21H18O4, from the seed oil of Pongamia pinnata. Karanjachromene is a 
fluorescent pyranoflavonoid. Such compounds are reported to have many 
interesting pharmacological and industrial applications. They reported on 
its isolation in significant yield and X-ray crystal structure. 
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Kalidhar et. al. (13) investigated the chemical composition of the 
roots of Pongamia pinnata. Four compounds, karanjin, pongachromene, 
pongapin and demethoxykanugin, were characterized from the 
methanolic extract of its roots by them. 
 
Chauhan and Cauhan (14) characterized two new flavone 
glycosides from the seeds of Pongamia pinnata on the basis of chemical 
and spectral evidence. 
 
Kumar et. al. (15) covered a review on the chemical composition of 
P. pinnata, and the insecticidal, antimicrobial, nematicidal and medicinal 
properties of compounds isolated from P. pinnata. 
 
Hemlata et. al. (16) characterized two flavone glycosided from P. 
Pinnata. It is used to treat eye diseases, lucoderma [leukoderma], piles, 
wounds, ulcers, skin diseases and rheumatic joints. Two new flavone 
glycosides from the ethanol extract of the heartwood (collected from 
Allahabad, India) were characterized on the basis of chemical and 
spectral evidence as 3,5,7,4'-tetrahydroxy-6,8,3'-trimethoxyflavone-3-O-
[alpha-L-arabinopyranosyl(13)]-beta-D-galacto pyranoside and 3,5,7,4'-
tetrahydroxy-6,8,3'-trimethoxyflavone-3-O-[{-alpha-L-arabinopyranosyl 
(13)}{-beta-D-galactopyranosyl(16)}-beta-D-galactopyranoside]. 
 
Punitha and Manoharan (17) evaluated the antihyperglycemic and 
antilipid peroxidative effect of ethanolic extract of Pongamia pinnata 
(Linn.) Pierre (Leguminosae) flowers (PpEt) in normal rats and alloxan 
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induced diabetic rats. Hyperglycaemia, elevated lipid peroxidation 
[thiobarbituric acid reactive substances (TBARS)] and disturbed 
nonenzymatic [Vitamin E, Vitamin C and glutathione] and enzymatic 
antioxidants status were noticed in alloxan induced diabetic rats. The oral 
administration of ethanolic extract of Pongamia pinnata flowers (300 
mg/kg bw) showed significant antihyperglycemic, and 
antilipidperoxidative effects and enhancement in antioxidants defence 
system in alloxan induced diabetic rats. However, no significant 
characteristic changes were noticed in blood glucose level as well as in 
lipid peroxidation and antioxidant status in normal rats treated with 
"PpEt" alone. We have also observed that the "PpEt" considerably 
reduced the blood glucose concentration in a similar extent to that of the 
reference drug glibenclamide (600 micro g/kg bw) in alloxan induced 
diabetic rats. Our results thus suggested that the "PpEt" could be used as a 
safe alternative antihyperglycemic drug for diabetic patients 
 
Gopinath et. al. (18) characterized from fruits of Pongamia pinnata 
four new furanoflavonoids, pongapinnol A-D (1-4), and a new 
coumestan, pongacoumestan along with thirteen known compounds 6-18. 
Compounds 16 and 17 are isolated for the first time from this plant. The 
structures of isolated compounds were elucidated on the basis of 
spectroscopic data interpretation. 
 
Vismaya et. al. (19) studied the gastroprotective properties of 
Karanj seed and found promising results for the treatment of gastric 
ulcers. Karanjin, a furano-flavonoid has been evaluated for anti-
ulcerogenic property by employing adult male albino rats. Karanjin 
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(>95% pure) was administered to these rats in two different 
concentrations, i.e. 10 and 20 mg/kg. Ulcers were induced in the 
experimental animals by swim and ethanol stress. Serum, stomach and 
liver-tissue homogenates were assessed for biochemical parameters. 
Karanjin inhibited 50 and 74% of ulcers induced by swim stress at 10 and 
20 mg/kg, respectively. Gastric mucin was protected up to 85% in case of 
swim stress, whereas only 47% mucin recovery was seen in ethanol stress 
induced ulcers. H+,K+-ATPase activity, which was increased 2-fold in 
ulcer conditions, was normalized by Karanjin in both swim/ethanol 
stress-induced ulcer models. Karanjin could inhibit oxidative stress as 
evidenced by the normalization of lipid peroxidation and antioxidant 
enzyme (i.e. catalase, peroxidase and superoxide dismutase) levels. 
Karanjin at concentrations of 20 mg/kg, when administered orally for 14 
days, did not indicate any lethal effects. There were no significant 
differences in total protein, serum glutamate pyruvate transaminase, 
serum glutamate oxaloacetate transaminase and alkaline phosphatase 
between normal and Karanjin-treated rats indicating no adverse effect on 
major organs. During treatment schedule, animals remained as healthy as 
control animals with normal food and water intake and body weight gain. 
 
 
 
                                                                                                  Review of Literature 
 
                                                                                                                                 38 
2.2. Dosage forms 
 
Vlad and Joseph (20) filed a European Patent  on the formulations 
of clear, thermodynamically stable and concentrated oil-in-water 
microemulsions. The oil-in-water microemulsion was comprising : a) at 
least 30% by weight of oil; b) from 1 to 30% by weight of a surfactant 
system having a hydrophilic lipophilic balance, HLB, comprised between 
9 and 18 Surfactants useful for the purpose of the present invention are 
approved for use in food type products and include notably Tween® 20, 
Tween® 40, Tween® 60, Tween® 80, Glycosperse® L-20 (polyethylene 
glycol sorbitan laurate), Glycosperse® O-20 (hexaethylene glycol 
sorbitan monooleate), Glycosperse® S-20 (polyoxyethylene sorbitan 
stearate), Polyaldo® 10-1-O K (decaglyceryl monooleate), Polyaldo® 10-
2-O K (decaglyceryl dioleate), Glycosperse® TS-20 (polyoxyethylene 
sorbitan tristearate), Lonzest® SMO-20 (monodehydrosorbitol 
monooleate), Span® 20, Span® 40, c) less than 20% by weight of co-
solvent,  propylene glycol, ethanol, mono- and di-saccharide sugars and 
sugar alcohols such as sorbitol, xylitol and mannitol. They used 
propylene glycol; and d) at least 30% by weight of water; relative to the 
total weight of the microemulsion. 
 
Bauer et. al. (21) filed a US patent on their invention concerning 
with a microemulsion of the oil-in water type, containing at least one 
polyglycerol ester as the emulsifier and at least one lipophilic substance 
as the internal phase. The emulsifier contains a triglycerol monofatty acid 
ester and the lipophilic substance is one from the group carotenoids, 
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especially, β-carotene, vitamins A, D, E and K and their derivatives and 
polyunsaturated fatty acids. 
 
Rosano (22) filed a US patent on the unique method for the 
preparation of oil-in-water microemulsions is described. In carrying out 
this method, microemulsions are prepared in a four-step process: (1) a 
surfactant is selected which is just barely soluble in the oil phase; (2) the 
surfactant thus selected is dissolved in the oil to be emulsified in an 
amount effective to yield a fine emulsion of the emulsified oil in an 
aqueous phase; and (3) the oil, together with its dissolved surfactant, is 
added to the water phase and shaken or stirred; and (4) finally, there is 
provided a second surfactant in the water phase which is somewhat more 
soluble in water than the first surfactant to produce a substantially clear 
microemulsion of oil in water.  
 
Owen and Yiv (23) filed a US patent on water-in-oil (w/o) 
microemulsion which readily converts to an oil-in-water (o/w) emulsion 
by the addition of aqueous fluid to the w/o microemulsion, whereby any 
water-soluble biologically-active material in the aqueous phase is 
released for absorption by the body. The w/o microemulsion is 
particularly useful for storing proteins and the like for long periods of 
time at room temperature and above until they are ready for use, at which 
time the addition of aqueous fluid converts the microemulsion to an o/w 
emulsion and releases the protein. 
 
Faiyaz Shakeel et. al. (24) investigated the potential of a 
nanoemulsion formulation for transdermal delivery of aceclofenac. 
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Various oil-in-water nanoemulsions were prepared by the spontaneous 
emulsification method. The nanoemulsions area was identified by 
constructing pseudoternary phase diagrams. The prepared nanoemulsions 
were subjected to different thermodynamic stability tests. The 
nanoemulsions formulations that passed thermodynamic stability tests 
were characterized for viscosity, droplet size, transmission electron 
microscopy, and refractive index. Transdermal permeation of aceclofenac 
through rat abdominal skin was determined by Franz diffusion cell. The 
in vitro skin permeation profile of optimized formulations was compared 
with that of aceclofenac conventional gel and nanoemulsion gel. A 
significant increase in permeability parameters such as steady-state flux 
(Jss), permeability coefficient (Kp), and enhancement ratio (Er) was 
observed in optimized nanoemulsion formulation. 
 
Carli et. al. (25) studied on the nanoemulsified composite (NECTM 
) delivery system, which is a patented technology based on the 
incorporation of a double microemulsion into microporous carrier. This 
approach was applied on the very water insoluble ubidecarenone drug. 
The resulting composite powder showed good technological properties 
such as flowability; also good stability was evidentiated, with size of the 
nano-droplets released from the systems maintained equal to the starting 
size also after a long storage. Furthermore very good biopharmaceutical 
properties were originated, with water solubility concentrations up to 50-
fold higher than pure ubidecarenone and oral absorption in rats up to 
three-fold greater than standard commercial products in terms of plasma 
levels and AUC. 
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Peira et.al. (26) reported on the pig-skin permeation and skin 
accumulation of miconazole nitrate (MCZ) from positively charged 
microemulsions containing water, 1-decanol/1-dodecanol (2:1, w/w), 
lecithin and/or decyl polyglucoside at different weight ratios, propylene 
glycol, 1,2 hexanediol and a cationic charge-inducing agent (stearylamine 
(ST), l-alanine benzyl ester (ALAB) or cetyltrimethylammonium bromide 
(CTAB)). Zeta-potential values of the positively charged microemulsions 
ranged from 14.2 to 37.5mV and mean droplet size from 6.0 to 16.8 nm. 
In vitro pig-skin permeation of MCZ after a single 24 h application was 
negligible for all microemulsions; accumulation from positively charged 
microemulsions was nearly twice that from their negatively charged 
counterparts. The increased accumulation might be ascribed to the 
interaction between positive microemulsive systems and negatively 
charged skin sites; no significant difference was observed among the 
various cationic charge-inducing agents. Skin accumulation from the 
microemulsion containing most lecithin was lower than those of other 
microemulsions; this was ascribed to the phase transformation from 
microemulsion to a liquid crystal system after skin contact. These results 
suggest that positively charged microemulsions could be used to optimize 
drug targeting without a concomitant increase in systemic absorption; 
ALAB, an ester of a natural aminoacid, is an appropriate cationic charge-
inducing agent. 
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2.3. Wound healing activity 
 
Karodi et. al. (27) explored the wound healing activity of R. 
cordifolia crude extract as well as its gel formulation against the specific 
microorganisms which generally infect wound. Rubia cordifolia Linn. 
(Rubiaceae) is popular all over the world for its medicinal uses in skin 
diseases like eczema, dermatitis, skin ulcers, etc. In India, it is used 
traditionally for various types of skin diseases. Hence, the present study 
was aimed to evaluate its scientific validity. The alcoholic extract and the 
hydrogel of same were investigated for the evaluation of its healing 
efficiency on excision wound model in mice. A different formulation of 
alcoholic extract was topically applied on the excision wound surface as a 
single dose. Wound area and histopathology were used to evaluate the 
effect on wound healing. The effect produced by gel, in terms of wound 
contracting ability, wound closure, decrease in surface area of wound, 
tissue regeneration at the wound site and histopathological characteristics 
were significant (p<0.01) in treated mice. The present study thus provides 
a scientific rationale for the traditional use of this plant in the 
management of the wounds. 
 
Jain et. al. (28) investigated the effect of Ageratum conyzoides root 
extract on wound healing and a comparable study of effect of polyherbal 
formulation containing Ageratum conyzoides, Ficus religiosa,Curcuma 
longa and Tamarindus indica, on wound healing process with respect to 
intact plant formulation through topical route. The wound healing 
property of Ageratum conyzoides appears to be due to the presence of its 
active principles, which accelerates the healing process and confers 
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breaking strength to the healed wound. Further, wound healing activity by 
polyherbal formulation was found to be better than ageratum treated 
groups in rat. It may be attributed to the synergistic action of ageratum 
constituent and the constituent of other plants present in the polyherbal 
formulation. 
 
Nalwaya et.al. (29) studied the wound healing activity of latex of 
calotropis gigantean, The entire wound healing process is a complex 
series of events that begins at the moment of injury and can continue for 
months to years. The stages of wound healing are inflammatory phase, 
proliferation phase, fibroblastic phase and maturation phase. The Latex of 
Calotropis gigantean (200 mg/kg/day) was evaluated for its wound 
healing activity in albino rats using excision and incision wound models. 
Latex treated animals exhibit 83.42 % reduction in wound area when 
compared to controls which was 76.22 %. The extract treated wounds are 
found to epithelize faster as compared to controls. Significant (p<0.001) 
increase in granuloma breaking strength (485±34.64) was observed. The 
Framycetin sulphate cream (FSC) 1 % w/w was used as standard. 
 
Shahbhag et. al. (30) studied the wound healing activity of 
alcoholic extract of kaempferia galanga in wistar rats. Three wound 
models viz. incision, excision and dead space wounds were used in this 
study. The parameters studied were breaking strength in case of incision 
wounds, epithelialisation and wound contraction in case of excision 
wound and granulation tissue dry weight, breaking strength and 
hydroxyproline content in case of dead space wound. The dexamethasone 
treated group showed a significant (P<0.001) reduction in the wound 
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breaking strength when compared to control group in incision type of 
wound model. Coadministration of K. galanga with dexamethasone had 
significantly (P<0.001) increased the breaking strength of dexamethasone 
treated group. In excision wound model, the percentage of the wound 
contraction was significantly (P<0.05) increased by K. galanga only on 
16th day and also it reversed the dexamethasone suppressed wound 
contraction on the 16 day. K. galangal significantly (P<0.001) reduced 
the time required for epithelialization and reversed the epithelialization 
delaying effect of dexamethasone significantly (P<0.001). 
 
Sharma et. al. (31) assessed the wound healing activity of benzene 
extracts of Momordica charantia fruit.Methanol extract of Momordica 
Charantia fruit was examined for wound healing potential in the form of 
1%w/v solution in the excision wound created on the dorsal side of 
experimental animals, the 1% w/v extract should considerable difference 
in wound models and the result were compatable to that of the standard 
drug betadine (5% w/w) in terms of wound contracting ability and wound 
closure time. Antibacterial activity of methanol extract of the plant was 
also carried out as a supporting evidence for its wound healing potential. 
The mean percentage wound closure was calculated on the 4 th, 8 th, 12 
th, 16 th and 15 th wounding days. The extract treated animals showed 
tastes epithelisation of wound (17.86 ± 0.19) then the control. The period 
of epithelisation was 21.23±0.37 in case of standard drug 5% betadine 
ointment.  
 
Kristine et. al. (32) studied the effect of barium sulfate on wound 
healing in the gastrointestinal tract of the rat. Sixty rats weighing 
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approximately 320 g were divided into four groups: Fifteen control rats 
had gastric, small-bowel, and colonic incisions; 15 rats had gastric 
incision; 15 rats had small-bowel incision; and 15 rats had colonic 
incision. Barium sulfate was placed into the incision before closure in all 
rats except those in the control group, and the effects were documented 
clinically and histopathologically for 3 months. Autopsy was performed 
in five rats from each group at 1, 4, and 12 weeks. The incisions in the 
rats receiving barium sulfate were compared with those in the control 
rats. There was no difference in the clinical course (weight gain, activity, 
and viability) between the control and experimental groups. Early and 
late autopsy findings and histopathologic grading of healing and 
inflammatory response were similar for both the control and experimental 
groups. Under the conditions of this study, the effect of barium sulfate on 
visceral transmural wound healing in the gastrointestinal tract of the rat 
was minimal. 
 
Nadagouda Smitha G. et. al. (33) evaluated the anti-inflammatory 
activity of aqueous extract of Pongamia pinnata stem bark (PPSB) in 
acute and chronic models of inflammation in albino rats. Oral 
administration of PPSB (400, 800 mg/kg) exhibited significant anti-
inflammatory activity in acute (carrageenin induced hind paw edema) and 
chronic (cotton pellet granuloma) models of inflammation. PPSB did not 
show any sign of toxicity and mortality up to a dose level of 8000 mg/kg, 
p.o. in rats. Both acute as well as chronic administration of PPSB (400 
and 800 mg/kg, p.o.) did not produce any gastric lesion in rats. These 
results indicated that PPSB hold significant anti-inflammatory activity 
 
 
 
                                                                                                  Review of Literature 
 
                                                                                                                                 46 
without ulcerogenic activity. Thus it can be used as anti-inflammatory 
agent in the treatment of various inflammatory diseases. 
 
Vigya Kesari et. al. (34) carried out oil analysis and antimicrobial 
activity from seeds of elite genotype of Pongamia pinnata. The highest oil 
yield (33%) from seeds was recovered in n-Hexane. Physico-chemical 
properties of crude oil established suitability of P. pinnata for its use as a 
potential biofuel crop. The total mono unsaturated fatty acid (oleic acid 
46%) present in seed oil was more in comparison to polyunsaturated fatty 
acid (33%) as analyzed by GC–MS. Seed oil also showed inhibition 
against the tested fungal and bacterial cultures. However, the efficacy of 
antimicrobial activity of the seed oil at four concentration levels (50%, 
80%, 90% and 100%) against various pathogenic indicators was found to 
be concentration- dependent. The obtained results confirmed the use of 
seed oil from well characterized elite genotype of Pongamia as diesel fuel 
and in pharmaceuticals. 
 
Kotade and Mohammed (35) verified the effect of S. indicum seeds 
oil on experimentally induced excision wound, incision wound, burn 
wound and dead space wound models in rats. Aloe vera was used as 
standard wound healing agent. A formulation of seeds and oil was 
prepared in carbopol at 2.5% and 5% concentrations and applied to the 
wounds. In the excision and burn wound models, the so treated animals 
showed significant reduction in period of epithelization and wound 
contraction (50%). In the incision wound model a significant increase in 
the breaking strength was observed. Seeds and oil treatment (250 mg and 
500 mg/kg; po) in dead space wound model, produced a significant 
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increase in the breaking strength, dry weight and hydroxyproline content 
of the granulation tissue. The results suggest that S. indicum seeds and oil 
applied topically or administered orally possesses wound healing activity. 
 
Agrawal et. al. (36) investigated Plantain banana (M. sapientum 
var. paradisiaca, MS) has been shown to possess ulcer healing activity. 
The present work with plantain banana was undertaken with the premise 
that the drug promoting ulcer healing could have effect on wound healing 
also. Wound healing activity of MS was studied in terms of (i) percent 
wound contraction, epithelization period and scar area; (ii) wound 
breaking strength and (iii) on granulation tissue antioxidant status 
[estimation of superoxide dismutase (SOD) and reduced glutathione 
(GSH), free radical (lipid peroxidation, an indicator of tissue damage) and 
connective tissue formation and maturation (hexuronic acid, 
hydroxyproline and hexosamine levels)] in excision, incision and dead 
space wound models respectively. The rats were given graded doses (50-
200 mg/kg/day) of aqueous (MSW) and methanolic (MSE) extracts of 
MS orally for a period of 10-21 days depending upon the type of study. 
Both extracts (100 mg/kg) when studied for incision and dead space 
wounds parameters, increased wound breaking strength and levels of 
hydroxyproline, hexuronic acid, hexosamine, superoxide dismutase, 
reduced glutathione in the granulation tissue and decreased percentage of 
wound area, scar area and lipid peroxidation when compared with the 
control group. Both the extracts showed good safety profile. Plantain 
banana thus, favoured wound healing which could be due to its 
antioxidant effect and on various wound healing biochemical parameters. 
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Mathivanan et. al. (37) found that Morinda leaf and fruit extracts 
are effective in healing the wounds using the animal model. The 
application of chloroform fruit extract of M. tinctoria topically on the 
excision wound surface of two different doses accelerated the wound 
healing process by decreasing the surface area of the wound. The fruit 
extracts of M. tinctoria at 20 mg/ml significantly healed the wound in rats 
within 15 days where complete healing was observed against 60% in 
untreated control. On day 3, all the treated animals exhibited considerable 
increase in the percentage of wound contraction as compared to control. 
The wound contraction was significantly increased in the subsequent days 
due to treatment of fruit extract at 10 and 20 mg/ml as compared to 
control. 
 
Devi and Meera (38) investigated antioxidant and anti 
inflammatory and wound healing effects of Litsea glutinosa in rats. The 
aqueous extract of Litsea glutinosa (250 and 500 mg/kg body weight) was 
studied for antinflammatory in animal models. The activity was studied in 
some acute models Viz carragenan, histamine and dextrin induced rats 
paw edema against indomethacin as standard, and it showed significant 
anti inflammatory ctivity in all the three models. The preliminary 
phytochemical analysis was carried out for different extracts. It was 
found that flavone glycosides, reducing sugars, aminoacids and tannins. 
The ethanolic extract was screened for wound healing activity by excision 
and incison wound model, in the form of an ointment having 2 
concentrations( 3 and 5 % w/w) of leaf extract in simple ointment base. 
Both the concentrations of the ethanolic extract showed significant 
response in both the wound types tested when compared with the control 
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group. Nitrofurazone ointment (0.2%w/w) was used as an standard drug. 
Antioxidant activity was determined by two in vitro methods- DPPH and 
H2O2 radical scavenging. The extract having significant (p<0.001) 
antioxidant activity was compared to control. BHT and Ascorbic acid 
were used as reference standard for antioxidant activity. On the basis of 
the results obtained suggest marked that extracts have significant Anti 
oxidant, Anti inflammatory and wound healing activity of Litsea 
glutinosa. The results supported the traditional use of this plant in some 
painful and inflammatory conditions. 
 
Singh et. al. (39) evaluated the wound healing activity of the leaf 
extracts and deoxyelephantopin isolated from Elephantopus scaber Linn. 
Using excision, incision, and dead space wound models in rats. The 
wound-healing activity was assessed by the rate of wound contraction, 
period of epithelialization, skin-breaking strength, weight of the 
granulation tissue, and collagen content. The wound-healing activity was 
more significant in deoxyelephantopin-treated animals. Histological 
studies of the granulation tissue also evidenced the healing process by the 
presence of a lesser number of chronic inflammatory cells, lesser edema, 
and increased collagenation than the control. 
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2.4. Antimicrobial activity 
 
Baswa et. al. (40) assessed the antibacterial activity of Karanj 
(Pongamia pinnata) and Neem (Azadirachta indica) seed oil in vitro 
against fourteen strains of pathogenic bacteria. Using the tube dilution 
technique, it was observed that 57.14 and 21.42% of the pathogens were 
inhibited at 500 microl/ml; 14.28 and 71.42% at 125 microl/ml; and 28.57 
and 7.14% at 250 microl/ml of Karanj and Neem oils, respectively. The 
activity with both the oils was bactericidal and independent of 
temperature and energy. Most of the pathogens were killed more rapidly 
at 4 degrees C than 37 degrees C. The activity was mainly due to the 
inhibition of cell-membrane synthesis in the bacteria. 
 
Kesari et. al. (41) carried out  the study on oil analysis and 
antimicrobial activity from seeds of elite genotype of Pongamia pinnata. 
The highest oil yield (33%) from seeds was recovered in n-Hexane. 
Physico-chemical properties of crude oil established suitability of P. 
pinnata for its use as a potential biofuel crop. The total mono unsaturated 
fatty acid (oleic acid 46%) present in seed oil was more in comparison to 
polyunsaturated fatty acid (33%) as analyzed by GC–MS. Seed oil also 
showed inhibition against the tested fungal and bacterial cultures. 
However, the efficacy of antimicrobial activity of the seed oil at four 
concentration levels (50%, 80%, 90% and 100%) against various 
pathogenic indicators was found to be concentration-dependent. The 
obtained results confirmed the use of seed oil from well characterized 
elite genotype of Pongamia as diesel fuel and in pharmaceuticals. 
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Gislene et. al. (42) evaluated the antimicrobial activity of plant 
extracts and phytochemicals with antibiotic susceptible and resistant 
microorganisms. In addition, the possible synergistic effects when 
associated with antibiotics were studied. Extracts from the following 
plants were utilized: Achillea millifolium (yarrow), Caryophyllus 
aromaticus (clove), Melissa offficinalis (lemon-balm), Ocimun basilucum 
(basil), Psidium guajava (guava), Punica granatum (pomegranate), 
Rosmarinus officinalis (rosemary), Salvia officinalis (sage), Syzygyum 
joabolanum (jambolan) and Thymus vulgaris (thyme). The 
phytochemicals benzoic acid, cinnamic acid, eugenol and farnesol were 
also utilized. The highest antimicrobial potentials were observed for the 
extracts of Caryophyllus aromaticus and Syzygyum joabolanum, which 
inhibited 64.2 and 57.1% of the tested microorganisms, respectively, with 
higher activity against antibiotic-resistant bacteria (83.3%). Sage and 
yarrow extracts did not present any antimicrobial activity. Association of 
antibiotics and plant extracts showed synergistic antibacterial activity 
against antibiotic-resistant bacteria. The results obtained with 
Pseudomonas aeruginosa was particularly interesting, since it was 
inhibited by clove, jambolan, pomegranate and thyme extracts. This 
inhibition was observed with the individual extracts and when they were 
used in lower concentrations with ineffective antibiotics. 
 
Kuete et. al. (43) used the crude methanolic extracts from Treculia 
africana and Treculia acuminata, three compounds isolated from T. 
africana and identified as, Phyllocoumarin (1), Catechin (2) and 6, 9-
dihydroxy-megastigmane-3-one (3), four compounds namely 2, 3, 2,3-
dihydroxypropyl-heptadecanoate (4), and Ferulic acid (5) isolated from T. 
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acuminata were tested for their antimicrobial activity against Gram-
positive bacteria (six species), Gramnegative bacteria (12 species) and 
three Candida species. The micro-dilution method for the determination 
of the minimal inhibition concentration (MIC) and the Minimal 
microbicidal concentration (MMC) was used. The MIC values obtained 
with the crude extracts varied from 78 to 156 μg/ ml against 12 (57.14%) 
and 20 (95.24%) of the 21 tested microorganisms respectively for T. 
acuminata and T. africana. Apart from compound 2 that prevented the 
growth of all the tested microorganisms, other bioactive compounds 
showed selective activity. The obtained results provide promising 
baseline information for the potential use of these crude extracts as well 
as some of the isolated compounds in the treatment of bacterial and 
fungal infections. 
 
Abdullahil et. al. (44) isolated two phenolic compounds, 
methylkarranjic (1) acid and pongamol (2) from the petroleum ether 
soluble fraction of an ethanolic extract of Derris indica seeds. The 
structures of these compounds were confirmed by LC-MS and a series of 
1D and 2D NMR data. The solvent solvent partionates of the ethanolic 
extract and compounds (1 and 2) exhibited moderate antibacterial activity 
against several test organisms. The minimum inhibitory concentrations 
(MICs) of 1 and 2 were found to be in the range of 32-128 μg/ml against 
Bacillus megatorium, Streptococcus β-haemolyticus, Shigella dysenteriae 
and E. coli.  
 
Nair and Chandra (45) screened 20 plants for antimicrobial 
activity. Medicinal plants are an important therapeutic aid for various 
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ailments. Scientific experiments on the antimicrobial properties of plant 
components were first documented in the late 19
th 
century. In India, from 
ancient times, different parts of medicinal plants have been used to cure 
specific ailments. Today, there is widespread interest in drugs derived 
from plants. This interest primarily stems from the belief that green 
medicine is safe and dependable, compared with costly synthetic drugs 
that have adverse effects. Natural antimicrobials can be derived from 
plants, animal tissues, or microorganisms. The shortcomings of the drugs 
available today, propel the discovery of new pharmacotherapeutic agents 
in medicinal plants. To determine the potential and promote the use of 
herbal medicine, it is essential to intensify the study of medicinal plants 
that find place in folklore. In this study, some selected plants of 
Saurashtra region, India, were screened for potential antibacterial activity.  
 
Pritima and Pandian (46) studied the antibacterial activity of  
Azadirachta indica. It is a commonly seen medicinal tree in India, which 
is considered Holy. The antibacterial potential of leaves of this tree was 
tested against certain reproductive tract infection (RTI) causing microbes, 
seen among women. Crude extracts were made using ethanol, methanol, 
acetone and water as solvents. Highest degree of activity was observed 
for ethanol followed by methanol, acetone and water extracts, which 
exhibited the same degree of activity. Escherichia coli and Enterococcus 
faecalis were highly susceptible to neem extracts of all solvents followed 
by Proteus mirabilis, Bacillus cereus and Staphylococcus aureus. Activity 
of Klebsiella pneumoniae was weak, while Neisseria gonohorreae was 
found to be relatively resistant to all forms of neem extract. 
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Kaushik et. al. (47) evaluated the antibacterial potential of dry 
fruits extracts of E. cardamomum against some selected bacterial species. 
Elettaria cardamomum can potentially be used in the treatment of various 
infectious diseases caused by microorganisms that are showing resistance 
to currently available antibiotics. Furthermore, active plant extracts can 
be subjected to various chemical evaluations by several methods. 
 
Wafaa A. Helmy  et. al. (48) studied the Biological and Anti-
microbial Activities of Aqueous Extracts from Neem Tree (Azadirachta 
indica . The aqueous extraction of neem leaves, seeds and seed hulls were 
carried out at 80 °C under acidic, neutral and alkaline conditions. The 
sulphation of nine crude extracts is carried out by chlorosulphonic acid as 
sulfating agent in formamide. Anticoagulation and fibrinolytic activities, 
as well as antimicrobial effect of aqueous extracts and their 
corresponding sulphates are demonstrated. The anticoagulation and 
fibrinolytic properties of total 9 crude extracts as well as their sulfated 
derivatives at 2mg/ml of extract were tested. No one of native and 
modified extracts showed anticoagulation activity. On the other hand, 
native water seed extract, and alkaline extracts of seed, seed-hulls and 
leaves as well as sulfated extracts activate the fibrinolytic processes. In 
addition, all of these native extracts and their  orresponding sulfates at 
concentration of 20 ìg/disc gave various inhibition activities against the 
Grampositive bacteria Staphylococcus aureus, the Gram-negative bacteria 
Escherichia coli, the yeasts Candida albicans, yeast-like Fungus) the 
fungi Aspergillus niger and Penicillium citrinum. In the light of these 
results we conclude that level of fibrinolytic and antimicrobial activities 
of the various extracts depends on both the protein and carbohydrate 
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contents. Generally, the high level of protein and carbohydrate contents 
of extract had better fibrinolytic and antimicrobial activities. Moreover, 
the sulfated extracts increase with the respect of the sulphate groups 
present. 
 
Jerajani  et. al. (49) described that Purim tablet is a polyherbal 
formulation indicated for management of chronic dermatitis and it 
contains extracts of Curcuma longa, Cassia fistula, Psoralea corylifolia, 
Saussurea lappa, Picrorhiza kurroa, Azadirachta indica, Tinospora 
cordifolia, Crataeva magna, Eclipta alba, Andrographis paniculata, 
Emblica ribes, Emblica officinale, Terminalia chebula and Terminalia 
belerica. This study was planned to evaluate efficacy and safety of Purim 
tablet in chronic dermatitis. Aatopic dermatitis is an expression of 
immunologic malfunction, which manifests as a spectrum of complicated 
clinical manifestations. This clinical trial observed highly significant 
rapid symptomatic relief and clinical improvement, with Purim tablets 
and there were no reported or observed adverse events. This study 
concluded that Purim tablets were clinically highly effective and safe in 
all types of chronic dermatitis.  
 
Okoli et. al. (50) evaluated the potentials of the leaves of the 
haemorrhage plant, Aspilia africana C. D Adams (Compositae) in wound 
care using experimental models. A. africana, which is widespread in 
Africa, is used in traditional medicine to stop bleeding from wounds, 
clean the surfaces of sores, in the treatment of rheumatic pains, bee and 
scorpion stings and for removal of opacities and foreign bodies from the 
eyes. The present study was undertaken to evaluate the potentials for use 
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of leaves of this plant in wound care. The leaves of A. africana possess 
constituents capable of arresting wound bleeding, inhibiting the growth of 
microbial wound contaminants and accelerating wound healing which 
suggest good potentials for use in wound care. 
 
Rath et. al. (51) assesses the antibacterial activity of Jasmine 
(Jasminum sambac L.) flower hydro steam distilled essential oil, 
synthetic blends and six major individual components against Escherichia 
coli (MTCC-443) strain. The activity was bactericidal. Minimum 
inhibitory concentration was determined by tube dilution technique, and 
the Minimum inhibitory concentration ranged between 1.9-31.25 μl/ml. 
Phenol coefficient of the oil, synthetic blends and components varied 
between 0.6-1.7. The activity of the chemicals was possibly due to the 
inhibition of cell membrane synthesis. 
 
Bose et.al. (52) reported that the bark of Polyalthia longifolia is 
traditionally reputed to lower blood pressure, stimulate respiration and 
help in fever and skin diseases, diabetes, hypertension and vitiated 
conditions of vata and pitta. Preliminary phytochemical investigation of 
various extracts of the bark of Polyalthia longifolia showed the presence 
of flavonoids, alkaloids, steroids and carbohydrates. An attempt has been 
made to isolate flavonoids and perform antioxidant and antimicrobial 
activity of the same. We carried out DPPH radical scavenging assay, 
nitric oxide scavenging assay, metal chelating activity and reducing 
power activity in antioxidant activity. In antimicrobial activity, we used 
six microorganisms, which included two Gram positive, two Gram 
negative bacteria and two fungi. Both the isolated flavonoids exhibited a 
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concentration-dependant free radical scavenging capacity. Isolated 
compounds showed promising results against various micro-organisms in 
comparison with standard drugs (Penicillin, Gentamicin and 
Ketoconazol). 
 
Umamaheswari and Shreevidya (53) studied the qualitative 
analysis of phytochemicals and antimicrobial activity of various solvent 
extracts of Boerhaavia diffusa L. (Family: Nyctaginaceae) leaves. The 
antimicrobial activity of different solvent extracts of B. diffusa L. leaves 
was tested against the Gram-positive and Gram-negative bacterial strains 
by observing the zone of inhibition. The Gram-positive bacteria used in 
the test were Staphylococcus aureus, Bacillus subtilis, Streptococcus 
faecalis and Micrococcus luteus, and the Gram-negative bacteria were 
Escherichia coli, Pseudomonas aeruginosa, Salmonella typhii, Klebsiella 
pneumoniae, Proteus vulgaris, Serratia marcescens, Shigella flexneri and 
Vibrio cholerae. It was observed that ethanol, methanol, chloroform, 
ethylacetate and aqueous extracts showed activity against Gram-positive 
and Gram-negative bacteria. The ethanol extract of B. diffusa L. leaves 
showed more activity against Gram-positive (e.g. S. aureus, zone of 
diameter 11 mm) and Gram-negative bacteria (e.g. E. coli, zone of 
diameter 9 mm) when compared to other solvent extracts except V. 
cholerae. The results confirmed the presence of antibacterial activity of B. 
diffusa L. leaves extract against various human pathogenic bacteria. 
 
Pavithra et. al. (54) reported on antibacterial activity of Delonix 
elata, Enicostemma axillare, Merremia tridentata, Mollugo cerviana and 
Solanum incanum whiche are used in traditional Indian medicine for the 
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treatment of various ailments like rheumatism, piles fever, skin diseases 
and snake bite. The antibacterial activity of organic solvent extracts of 
these plants were determined by disc diffusion and broth dilution 
techniques against gram-positive bacterial strains (Bacillus subtilis, 
Staphylococcus aureus) and gram-negative bacterial strains (Escherichia 
coli, Klebsiella pneumoniae, Pseudomonas aeruginosa). Results revealed 
that the chloroform and methanol extracts of D. elata and methanol 
extracts of M. cerviana exhibited significant antibacterial activity against 
gram-positive and gram-negative strains with minimum bactericidal 
concentration (MBC) ranging from 1.5 to 100 mg/ml. Methanol extracts 
of M. tridentata exhibited activity only against gram-positive bacterial 
strains with MBC ranging from 12.5 to 100 mg/ml. Extracts of E. axillare 
and S. incanum showed activity only against B. subtilis and were not 
bactericidal at 100 mg/ml. The most susceptible organism to the organic 
extracts from all the studied plants was B. subtilis and the most resistant 
organism was P. aeruginosa. The presence of phytochemicals such as 
alkaloids, tannins, triterpenoids, steroids and glycosides in the extracts of 
these plants supports their traditional uses as medicinal plants for the 
treatment of various ailments. The present study reveals potential use of 
these plants for developing new antibacterial compounds against 
pathogenic microorganisms. 
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2.5. Hemostatic activity 
 
Shamsher et. al. (55) investigated the feasibility of delivering 
aspirin transdermally from eudragit and polyvinyl acetate (PVA) matrix-
type patches to enhance its antithrombotic efficiency of aspirin. 
Transdermal films containing mixture of eudragit RL: eudragit RS and 
polyvinyl acetate were fabricated. Eudragit RL: eudragit RS (5:1) films 
containing 30 mg/ transdermal patch aspirin showed maximum release 
(11.891.1g/cm2) after 24 hrs as compared to PVA films. With regards 
to appearance eudragit films were also wrinkle free, uniform, flexible and 
transparent with good adhesion property to skin. The effect of turpentine 
oil and lemon oil at different concentrations on the in vitro percutaneous 
absorption of aspirin from eudragit copolymer patches through rat skin 
was investigated. Two formulation containing 50 mg/transdermal patch 
ASA with 0.042 ml turpentine oil and 0.042 ml lemon oil showed a 
significantly higher flux of ASA 4.22 µg/cm2/hr and 38.52 g/cm2/hr 
respectively. The optimized formulations influenced the blood 
coagulation parameters (bleeding time, prothrombin time, Activated 
partial prothrombin time) significantly by means of affecting both the 
extrinsic coagulation system and the intrinsic coagulation system as 
compared to orally administered and control gel formulations.  
 
Kamal et. al. (56) described that the prothrombin time (PT) and 
activated partial thromboplastin time (APTT) are among the most 
commonly ordered coagulation tests. In 2005, more than 140,000 PT and 
more than 95,000 APTT tests were performed at Mayo Clinic. The most 
common indications for ordering these tests include anticoagulant 
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monitoring, initial evaluation of hemorrhage, and, although not generally 
indicated, routine preoperative screening. In addition, the bleeding time 
(BT) test, which is infrequently performed, is still available in certain 
institutions. Abnormal results from these tests (prolonged PT, APTT, and 
BT), especially from tests conducted for initial evaluation of hemorrhage 
or for preoperative screening, may pose a diagnostic dilemma to the 
nonhematologist. We review the essential factors affecting test results; 
provide a practical approach to the evaluation of a prolonged PT, APTT, 
and BT; and offer suggestions on which reflexive tests are appropriate 
and when to consider a subspecialty consultation. 
 
Mustard and Murphy (57) studied blood coagulation, platelet 
survival and turnover, and blood lipids in a group of seven patients 
maintained successively on each of three rigidly controlled diets for a 
period of four or more weeks each. They concluded that dietary control 
influences not only serum lipid values but also blood coagulation in vitro 
and platelet economy in vivo. 
 
Saxena et. al. (58) described that it is important to go in a stepwise 
approach to diagnose spectrum of bleeding disorders, so that minimum 
tests are undertaken to make a definitive diagnosis and to avoid 
unnecessary tests and laboratory load. Depending on the abnormalities 
observed in the short screening, extended screening tests can be 
performed followed by specialized diagnostic tests. Bleeding time is 
prolonged in thrombocytopenia and platelet function disorders (PFD). If 
platelet count is normal, extended screening tests such as RVVT, PF3 
availability and clot retraction can be performed. Russel viper venom 
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directly activates FX, in presence of PF3,is an indicator of common 
pathway of coagulation. However, if there is deficiency of PF3 as 
obtained in PFD and APTT PT are normal, its prolongation indicates 
PFD. These can be tested invitro by performing RVVT with and without 
inosithin it is highly suggestive of underlying PFD. In such cases, 
diagnostic tests for PFD such as platelet aggregation with ADP, ADR, 
AA, Collagen and Ristocetin can be performed followed by electron 
microscopy if possible. Few of the interesting cases also have been 
discussed in the text. 
 
Kale et. al. (59) screened Various extracts of the leaves of Tridax 
procumbens Linn for hemostatic activity by studying the clotting time of 
10 human volunteers employing Lee-White’s method performed in vitro. 
Out of the ethanolic extract, fresh leaf juice and petroleum extract, 
ethanolic extract showed positive activity. The experiment was 
successfully tested for statistical significance by employing the paired t-
test. 
 
Bhagat et. Al. (60) designed to determine the antiproliferative 
activity of three extracts (alcoholic, hydro-aqueous and aqueous) and 
their fractions from the root part of Calotropis procera using human oral 
(KB) and central nervous system (SNB-78) cancer cell lines as a model 
system. KB and SNB-78 cells were cultured in the presence of extracts 
and fractions at various concentrations (10, 30 and100 μg/ml) for 48 h, 
and the percentage of cell viability was evaluated by the sulforhodamine-
B (SRB) assay. Our result indicates that out of the three extracts of C. 
procera (root), alcoholic extract had shown greater potential for growth 
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inhibition followed by hydro-aqueous extract at three different 
concentration of 10 μg/ml, 30 μg/ml and 100 μg/ml in a dose-dependent 
manner, whereas aqueous extract was found to be least active against 
both oral and CNS human cancer lines. On evaluation of the fractions 
prepared from alcoholic and hydro-aqueous extracts, it was observed that 
chloroform fraction from alcoholic extract was antiproliferative for oral 
(KB) cancer cell line and n-butanol fraction from alcoholic extract was 
antiproliferative for CNS cancer cell line than remaining fractions at three 
different concentration of 10 μg/ml, 30 μg/ml, 100 μg/ml in a dose-
dependent manner. The result indicated that the root part of C. procera 
possess in vitro cytotoxicity against oral and CNS human cancer cell 
lines. Further investigations are required to obtain the clinically important 
lead molecules for the drug development. 
 
Gupta et. al. (61) compared the postoperative blood loss in patients 
not receiving magnesium after cardiopulmonary bypass (CPB) with the 
group who received magnesium and to studied the requirement of blood, 
fresh frozen plasma (FFP) and platelets within 24 hours after surgery. 
This prospective randomized controlled study was conducted in 80 adult 
patients on oral aspirin undergoing elective CABG requiring CPB. 
Hypomagnesaemia is a common complication after cardiopulmonary 
bypass (CPB) and predisposes to the development of cardiac arrhythmias. 
Previous studies showed that intravenous magnesium reduces the 
incidence of postoperative cardiac arrhythmias but it also inhibits platelet 
function. Group A patients had not received magnesium infusion after 
recovery from CPB. Group B patients received magnesium infusion after 
recovery from CPB. Postoperative bleeding was assessed in both the 
 
 
 
                                                                                                  Review of Literature 
 
                                                                                                                                 63 
groups. All the data were statistically analyzed. There was a insignificant 
increase in 24 hours postoperative drainage in magnesium recipient group 
compared to control group (p>0.05). Requirements of blood and blood 
products to maintain haematocrit and coagulation profile revealed 
insignificant (p >0.05). Increase in requirement of PRC, FFP and platelets 
in magnesium recipient patients than the control group. Incidence of atrial 
fibrillation (Gr A 2.5%, Gr B 2.5%) and atrial extrasystoles (Gr A 2.5%, 
Gr B 10%) revealed comparable (p>0.05) between the groups, but 
incidence of ventricular arrhythmias were significantly ( p<0.05) high in 
the patients of Gr A (17.5%) than Gr B (5%). Magnesium may be 
administered to patients who continue pre-operative aspirin to undergo 
on-pump CABG surgery. 
 
Sharma and Kulshrestha (62) performed comparative evaluation of 
enfenamic acid and few NSAID on biochemical parameters like blood 
sugar and uric acid and on baematological parameters like clotting time, 
platelet count, euglobulin clot lysis time and plasma fibrinogen content in 
rabbits. Aspirin and ibuprofen per se induced hyperglycemia while 
tolmetin and indometbacin produced hypoglycaemic response. However, 
with enfenamic acid, hypoglycaemlc resposne was more marked in higher 
doses. Aspirin and tolmetin exhibited significant hypouricaemic effect, 
enfenamic acid and ibuprofen were less potent in this respect. The study 
showed increased plasma fibrinogen content and euglobulin clot lysis 
time with aspirin, tolmetin and indomethacin while ibuprofen produced 
an increase in plasma fibrinogen content and had no effect on euglobulin 
clot lysis time, enfenamic acid had no effect on both the parameters. 
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Phatnaik and Parabar (63) investigated that the anti-inflammatory 
drug, Indomethacin. was found to have no significant effects on whole 
blood clotting time. one-stage prothrombin time, qualitative test for 
fibrinolysis time, clot retraction fibrinogen; visual thrombelastographic 
observations. The results indicated that the drug has no adverse effect on 
blood coagulation. 
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3.1. Introduction 
 
The function of skin is to serve as a protective barrier against the 
environment. Wounds are physical injuries that result in an opening or 
breaking of the skin. The wound may be defined as a loss or breaking of 
cellular and anatomic or functional continuity of living tissues. Healing is 
a complex biological process initiated in response to an injury that 
restores the function and integrity of damaged tissues. Healing process 
can be broadly categorized into three stages: inflammatory phase 
(consisting of the establishment of homeostasis and inflammation); 
proliferate phase (consisting of granulation, contraction and 
epithelialisation) and finally the remodeling phase which ultimately 
determines the strength and appearance of the healed tissue.  
 
Microbial infection of wounds delays healing (1) and causes a 
more pronounced acute inflammatory reaction (2) which can lead to 
further tissue injury and damage. The antimicrobial activity may partly 
contribute to the wound healing effect by eliminating infection thus 
allowing the natural tissue repair processes to start. The antimicrobial 
activity may also play a useful role in accelerating the healing of old 
wounds by eradicating already established infection. The antimicrobial 
activity of honey and Melaleuca alternifolia is believed to underlie their 
usefulness as alternative therapy in wound healing (3-4). Since wound 
healing and antimicrobial activity are also interrelated with blood 
coagulation in the wound, the study of hemostatic activity and their 
influence on each other is of significant important. 
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In India, there has been interest in the potential of medicinal plant 
for development of drugs with wound healing efficiency as mentioned in 
a popular form of Indian medicine known as Ayurveda (5). Medicinal 
herbs are an indispensible part of traditional medicine. All parts of the 
plant Pongamia pinnata, also called as Derris indica, have been used as a 
crude drug for the treatment of tumours, piles, skin diseases, itches, 
abscess, painful rheumatic joints, wounds, ulcers, diarrhea, etc. (6). 
Pongamia pinnata plant, known as Karanj, is used for anti-infl ammatory, 
anti-plasmodial, anti-nonciceptive, anti-hyperglycaemics, anti-
lipidoxidative, anti-diarrhoeal, anti-ulcer, anti-hyperammonic and 
antioxidant. Its oil is a source of biodiesel (7).  
Fig. 3.1: Karanj Tree 
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Fig. 3.2: Karanj Flowers 
 
 
Fig. 3.3: Karanj Fruits 
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Fig. 3.4: Karanj Pods 
 
 
Fig. 3.5: Karanj Seeds 
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Fig. 3.6: Karanj Oil 
 
 
 
Karanj oil and medicated karanj oil are used widely by local 
Ayurvedic Practitioners (Vaidraj) in rural areas of Gujarat for the 
treatment of rheumatism and curing skin infections. It is used externally 
for healing, antiseptic, and hemostatic effect by learned Ayurvedic 
Practitioners. However to the best of our knowledge, a systematic and 
scientific study on wound healing efficiency along with antimicrobial and 
hemostatic activity of seed oil of Karanj (Pongamia pinnata) has not been 
undertaken. Hence, the present investigation was aimed to evaluate 
systematically and scientifically the wound healing, antibacterial, and 
hemostatic activity of karanj oil and its formulations. 
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3.2. Materials and Methods 
3.2.1. Materials 
Plant materials: Karanj oil was procured from Shree Shankar Ayurvedic 
Pharmacy, Changodar, Ahmedabad (Gujarat).  
Medicated Karanj oil was gift sample from Rashvaidh, Chuda, 
Surendranagar (Gujarat).  
Standard Drug formulation: 1% w/w framycetin sulphate cream (FSC) 
was procured from local Madhuvan Medical Store, Ahmedabad (Gujarat). 
Animal commercial diet was procured from Pranav Agro Ltd., Vadodara. 
Other chemicals and materials used were of high quality standards. 
Table 3.1: List of Materials 
S.N. Name of material Supplier 
1 Gum acacia Laser Laboratories (Ahmedabad)
2 Tween 80 Laser Laboratories (Ahmedabad)
3 Span 60 Laser Laboratories (Ahmedabad)
4 Cremophor RH 40 Generous gift from Sun 
Pharmaceutical Ind. Ltd., 
(Vadodara) 
5 Glyceryl dilaurate Generous gift from Sun 
Pharmaceutical Ind. Ltd., 
(Vadodara) 
6 Ethyl oleate Generous gift from Sun 
Pharmaceutical Ind. Ltd., 
(Vadodara) 
7 Transutol P Generous gift from Sun 
Pharmaceutical Ind. Ltd., 
(Vadodara) 
8 Stearic Acid Generous gift from Sun 
Pharmaceutical Ind. Ltd., 
(Vadodara) 
9 Ethoxylated cetosteryl alcohol 
(Volpo CS20) 
Generous gift from Sun 
Pharmaceutical Ind. Ltd., 
(Vadodara) 
10 Stearyl alcohol  
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11 Propylene glycol Generous gift from Sun 
Pharmaceutical Ind. Ltd., 
(Vadodara) 
12 Agar Generous gift from Sun rise 
Remedies (Ahmedabad) 
13 Peptose Generous gift from Sun rise 
Remedies (Ahmedabad) 
14 Lab lemco (Beef Extract) Generous gift from Sun rise 
Remedies (Ahmedabad) 
15 Sodium chloride Laser Laboratories (Ahmedabad)
16 Sodium hydroxide Laser Laboratories (Ahmedabad)
17 Light ether Generous gift from Sun 
Pharmaceutical Ind. Ltd., 
(Vadodara) 
18 Sodium pentobarbital Generous gift from Sun 
Pharmaceutical Ind. Ltd., 
(Vadodara) 
19 100 mM citrate buffer pH 4.5 Generous gift from Sun 
Pharmaceutical Ind. Ltd., 
(Vadodara) 
20 Human thromboplastin 
(Thromborel®) 
Generous gift from Sun 
Pharmaceutical Ind. Ltd., 
(Vadodara) 
21 Human placenta lipid extract 
(Pathrombin®) 
Generous gift from Sun 
Pharmaceutical Ind. Ltd., 
(Vadodara) 
22 Diethylbarbiturate-citrate 
buffer, pH 7.6 
Generous gift from Sun 
Pharmaceutical Ind. Ltd., 
(Vadodara) 
23 Bovine test-thrombin 30 
IU/ml 
Generous gift from Sun 
Pharmaceutical Ind. Ltd., 
(Vadodara) 
24 Calcium chloride Loba Chemie Pvt. Ltd (Bombay) 
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3.2.2 Methods 
3.2.2.1 Preparation of Karanj oil formulations 
3.2.2.1.1 Karanj oil:  
Karanj oil was procured from Shree Shankar Ayurvedic Pharmacy, 
Changodar, Ahmedabad (Gujarat). It was stored in well closed container 
at room temperature. 
3.2.2.1.2 Medicated Karanj oil: 
Medicated Karanj oil was gift sample from Rashvaidh, Chuda, 
Surendranagar (Gujarat). 
3.2.2.1.3 Emulsion of Karanj oil: 
Emulsion of the karanj oil was prepared by dry gum method using 
gum acacia, Tween 80, or/and Span 20 as emulsifiers. The required 
quantity of karanj oil was weighed and transferred in a glass beaker. 
Weighted quantity of gum, emulgent, or/and co-emulgent (Acacia, Tween 
80, Span 20) were mixed in the oil with stirring into a mortar. The 
measured volume of distilled water was added in portion with trituration. 
Remaining quantity of distilled water was added dropwise with 
trituration. The creamy thick emulsion was obtained. The emulsion was 
stored in white glass bottle at RT.  
The composition of emulsion containing 20% to 40% karanj oil 
prepared using gun acacia is presented in Table 3.2.  
Table 3.2: Formulation Composition of Emulsion containing Karanj 
Oil Using Gum Acacia 
Batch Code Ingredient (%w/w) 
E1 E2 E3 E4 E5 
Karanj oil 20 25 30 35 40 
Gum acacia 5 6.25 7.25 8.75 10 
Dist. Water q.s. to 100 100 100 100 100 
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3.2.2.1.3.1 Experimental Design: 
To optimize the concentration of emulsifiers, a 32 factorial design 
was adopted using the concentration of Tween 80 (X1) and Span 20 (X2) 
as independent variables at three levels: low (-1), medium (0) and high 
(1). The factorial design batches S1-S9 were prepared by dry gum method 
and their composition is presented in Table 3.3. 
 
Table 3.3: Composition of Batches of Factorial Design for Karanj 
oil Emulsion 
Batch Karanj Oil 
(%w/w) 
Tween 80  
(% w/w) 
Span 20  
(% w/w) 
S1 30 7.5 4 
S2 30 10 4 
S3 30 12.5 4 
S4 30 7.5 5 
S5 30 10 5 
S6 30 12.5 5 
S7 30 7.5 6 
S8 30 10 6 
S9 30 12.5 6 
As per the results of the experimental design, the optimized 
formulation of karanj oil emulsion using Tween 80 and Span 20 is 
presented in Table 3.4. 
Table 3.4: Formulation of Karanj Oil Emulsion 
S.N. Ingredients Quantity (% w/w) 
1 Karanj Oil 30% 
2 Tween 80 10% 
3 Span 20 5% 
4 Distilled water 55%. 
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3.2.2.1.4 Microemulsion of Karanj Oil: 
 
The microemulsion of karanj oil (10 to 20%w/w) were prepared 
using surfactant, co-surfactant, solvent, and co-solvent like Cremophor 
RH 40, Glyceryl dilaurate, Tween 80, Ethyl oleate, Transutol P, etc. The 
weighed quantity karanj oil was mixed with surfactant-co-surfactant 
mixture in a glass beaker. The measured quantity of solvent, co-solvent, 
or/and distilled water were added dropwise with stirring at 5000 RPM.  
Transparent slightly thick microemulsion was obtained. The emulsion 
was packed in white glass bottle and kept at RT.  
 
3.2.2.1.4.1 Experimental Design: 
To optimize the concentration of co-surfactant, surfactant, and 
solubilizer, a 33 factorial design was adopted using the concentration of 
glyceryl dilaurate  (X1), Cremophor RH 40 (X2), and Transutol P (X3) as 
independent variables at three levels: low (-1), medium (0) and high (1). 
The composition of factorial design batches F1-F27 is shown in Table 3.5. 
As per the results of the experimental design, the optimized 
formulation of karanj oil microemulsion using Glyceryl dilaurate, 
Cremophor RH 40, and Transcutol P is presented in Table 3.6. 
Table 3.6: Formulation of Karanj Oil Microemulsion 
S.N. Ingredients Quantity (% w/w) 
1 Karanj Oil 15% 
2 Glyceryl dilaurate 12.5% 
3 Cremophor RH 40 22.5% 
4 Transcutol P 10% 
5 Distilled water q.s. 
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Table 3.5: Composition of Batches of Factorial Design for Karanj oil 
Microemulsion 
Batch Karanj Oil 
(%w/w) 
Glyceryl dilaurate 
(% w/w) 
Cremophor 
RH 40 (% w/w) 
Transcutol 
(% w/w) 
F1 15 7.5 17.5 7.5 
F2 15 7.5 20 7.5 
F3 15 7.5 22.5 7.5 
F4 15 10 17.5 7.5 
F5 15 10 20 7.5 
F6 15 10 22.5 7.5 
F7 15 12.5 17.5 7.5 
F8 15 12.5 20 7.5 
F9 15 12.5 22.5 7.5 
F10 15 7.5 17.5 10 
F11 15 7.5 20 10 
F12 15 7.5 22.5 10 
F13 15 10 17.5 10 
F14 15 10 20 10 
F15 15 10 22.5 10 
F16 15 12.5 17.5 10 
F17 15 12.5 20 10 
F18 15 12.5 22.5 10 
F19 15 7.5 17.5 12.5 
F20 15 7.5 20 12.5 
F21 15 7.5 22.5 12.5 
F22 15 10 17.5 12.5 
F23 15 10 20 12.5 
F24 15 10 22.5 12.5 
F25 15 12.5 17.5 12.5 
F26 15 12.5 20 12.5 
F27 15 12.5 22.5 12.5 
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3.2.2.1.5 Cream of Karanj oil: 
 
The cream containing karanj oil was prepared by hot emulsification 
method. The weighed quantity of propylene glycol was added in distilled 
water in a glass beaker. Ethoxylated cetosteryl alcohol was weighed and 
added. The mass was heated at 70°C on a water bath and transferred to a 
mortar. The measured quantity of karanj oil, stearic acid, and stearyl 
alcohol were heated to 70°C in a beaker. The hot oil phase was added 
slowly to hot water phase with trituration. The mixture was stirred till 
temperature came down to room temperature. The cream was packed in a 
container and kept at RT. The formulation of karanj oil cream is depleted 
in Table 3.7. 
  
Table 3.7: Formulation of Cream of Karanj Oil 
S.N. Ingredient Quantity (%w/w)
1 Karanj Oil 30 
2 Stearic Acid 05 
3 Ethoxylated cetosteryl alcohol (Volpo CS20) 10 
4 Stearyl alcohol 05 
5 Propylene glycol 10 
6 Purified water 40 
 
 
3.2.2.1.6 Evaluation of Karanj oil Formulations: 
 
Freeze Thawing 
The formulations were subjected to 3 to 4 freeze-thaw cycles, which 
included freezing at -4°C for 24 hours followed by thawing at 40°C for 
24 hours. Centrifugation was performed at 3000 rpm for 5 minutes. The 
formulations (n=3) were then observed for phase separation. 
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Droplet Size Measurement 
One hundred microliters of the formulation was diluted with distilled 
water to 250 mL in a beaker and gently mixed using a glass rod. The 
resultant diluted formulation was then subjected to particle size analysis 
(Malvern Mastersizer, Worchestershire, UK, equipped with 2000 Hydro 
MU) with a particle size measurement range of 0.02 to 2000 μm. Particle 
size was calculated from the volume size distribution (n=3). 
Optical birefringence 
The microemulsion was checked visually to confirm absence of other 
phases. The microemulsion was characterized for % Transmittance 
measured by UV Spectrophotometer at 520nm. Distilled water was 
employed as the reference solution with a transmittance of 100% (n=3).  
Measurement of zeta potential 
The zeta potential of the microemulsion was measured using a Zetasizer 
Nano-ZS (Malvern Instruments, UK). The electrophoretic mobility 
(µm/s) was measured using small volume disposable zeta cell and 
converted to zeta potential by in-built software using Helmholtz-
Smoluchowski equation. The measurement was done at 25°C in triplicate. 
Viscosity determination 
The viscosity of each formulation was measured using a DV-E 
viscometer (Brookfield Engineering Laboratories, Middleboro, MA, 
USA) at 25˚C in triplicate. The samples (n=3) were contained in 
cylindrical bottles, 2.4 cm in diameter and 4.5 cm in height. The 
measurement was performed with a No. 16 spindle and the shear rate was 
set at 100 RPM. 
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3.2.2.2 Wound healing activity: 
 
Wistar rats of either sex weighing 150-200 gm were used for the 
study (8). All the animals were maintained under controlled room 
temperature (22±2°C) and relative humidity (50±5%) with 12:00 hr light, 
12:00 hr dark cycle. The animals were housed in colony cages (three 
animals per cage) with free access to commercial diet (Pranav Agro Ltd., 
Baroda) and water ad libitum during the investigation period. All the 
animals were acclimatized to the laboratory environment for 5 days 
before the experimentation. Six animals (rats) per group comprising of 
three males and three females were used in each experiment set, unless 
otherwise specified. The study protocol was approved by the Institutional 
Animal Ethics Committee (IAEC) of C.U. Shah College of Pharmacy and 
Research, Wadhwan. 
 
Excision wound model was used to evaluate the wound healing 
efficiency. The rats were inflicted with excision wounds as described by 
Morton and Malone (9) under light ether anesthesia. A circular wound of 
about 300 sq. mm and 2 mm depth was made on depilated ethanol 
sterilized dorsal thoracic region of the rats. The animals were divided into 
seven groups of six each. The animals of group I was left untreated and 
considered as control. The rats of Group II were served as reference 
standard and received 1% w/w framycetin sulphate cream (FSC), the 
animal group III and IV were treated with Karanj oil and medicated 
karanj oil, respectively. The animal group V, VI and VII were treated 
with Karanj oil emulsion, Karanj oil microemulsion and karanj oil cream, 
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respectively. The karanj oil or its formulation was topically applied once 
a day at oil dose of 200 mg/kg/day, starting from the day of the operation, 
till complete epithelialisation. The parameters studied were wound 
closure and epithelialisation time. The wounds were traced on mm2 graph 
paper on day 0, 4, 8, and 16 and thereafter on alternate days until healing 
was completed. The period of epithelialisation was the number of days 
required for falling of the dead tissue remnants of the wound without any 
residual raw wound. The results of wound area and epithelialisation time 
were depleted in Table 3.8.  
 
Table 3.8: Results of Wound Healing Activity of Karanj oil 
Formulations 
Wound area in mm2 on Period of 
epithelialisation
Animal 
Group 
0 day 4 day 8 day 16 day days 
Group I 289.25 
±14.01 
267.69 
±18.85 
238.64 
±20.50 
180.39
±11.55 
32.17*  
± 3.06 
Group II 283.89 
±19.42 
180.46*
±13.30 
95.41* 
±17.72 
17.04* 
±5.67 
19.33* 
 ± 1.21 
Group III 298.09 
±17.72 
246.63 
±22.58 
207.69 
±23.82 
144.53 
±41.77 
27.83*  
± 1.47 
Group IV 296.25 
±10.49 
241.45 
±20.86 
195.83* 
±10.02 
126.15*
±27.88 
25.66* 
 ± 2.58 
Group V 292.41 
±16.27 
189.98*
±15.33 
105.94* 
±7.96 
45.78* 
±12.77 
21.50* 
±1.87 
Group VI 286.23 
±12.47 
156.23*
±12.78 
77.20* 
±18.05 
10.53* 
±1.88 
17.67* 
±0.52 
Group VII 284.89 
±17.74 
170.93*
±11.21 
87.39* 
±17.22 
16.71* 
±3.62 
18.50* 
±1.05 
F 0.7617 39.56 91.13 73.95 50.93 One way 
ANOVA P 0.6046 0.0001 0.0001 0.0001 0.0001 
*P<0.05, df (group)=6, n=6 in each group 
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The percentage of wound closure was calculated by the formula: 
100% X
woundofareaInitial
woundofareadaythNwoundofareaInitialclosureWound −=
and the results of % wound closure were presented in Table 3.9.  
 
Table 3.9: Results of % Wound Closure of Karanj oil 
Formulations 
% Wound closure on Animal 
Group 0 day 4 day 8 day 16 day 
Group I 0 7.45 17.50 37.64 
Group II 0 36.43 66.39 94.00 
Group III 0 17.26 30.33 51.51 
Group IV 0 18.50 33.90 57.42 
Group V 0 35.03 63.77 84.34 
Group VI 0 45.42 73.03 96.32 
Group VII 0 40.00 69.33 94.13 
 
3.2.2.3. Antimicrobial activity: 
Karanj oil and its formulations were evaluated for their potential 
antibacterial activity by the standard agar well diffusion assay (10). Petri 
dishes (100 ml) containing 30 ml of agar medium were seeded with 0.1 
ml of microbial suspension (about 108 to 109 CFU/ml) of Gram positive 
(Bacillus subtilis MTCC No. 441, Staphylococcus aureus MTCC No. 
737) and Gram negative (Escherichia coli MTCC No. 1687, Salmonella 
typhi MTCC No. 98) bacteria and media was allowed to solidify. Wells 
of 6 mm diameter (4 wells per Petri dish) were cut into solidified agar 
media using a sterilized cup-borer. 0.05 ml/mg of each sample was 
poured in the respective well and the dishes were incubated at 37 °C for 
24 hrs.  
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The antibacterial activity was expressed in terms of the mean of 
diameter of zone of inhibition including 6mm diameter of well (in mm 
measured horizontally and vertically) produced by each sample at the end 
of incubation period. Sterilized distilled water was served as negative 
control. 1gm of 1% W/W framycetin sulphate cream (FSC) ointment 
diluted and mixed with 9ml of sterilized distilled water was used as 
standard i.e. positive control. The microbial assay was performed in 
triplicate and the results were presented in Table 3.10 as mean of the 
three values ± standard deviation.  
 
Table 3.10: Results of Zone of Inhibition of Karanj oil and its 
Formulations 
Diameter of the zone of inhibition (mm) 
Gram positive Gram negative 
Bacteria 
Bacillus 
subtilis 
Staphylococc
us aureus 
Escherich
ia coli 
Salmonella 
typhi 
Negative 
control 
No No No No 
Positive 
control 
34.33 
±5.03 
32.67 
±5.51 
29.33 
±4.16 
24.67 
±4.51 
Karanj oil 10.33* 
±1.53 
14.33* 
±4.16 
11.67 
±3.51 
10.67 
±4.04 
Medicated 
Karanj oil 
12.33* 
±3.06 
19.33* 
±4.73 
13.67 
±4.16 
11.67 
±4.04 
Emulsion 17.33* 
±3.51 
22.33 
±4.51 
16.33 
±3.51 
15.33 
±3.51 
Micro 
emulsion 
24.33* 
±2.08 
24.33 
±5.03 
18.67 
±6.51 
17.67 
±5.03 
Cream 15.67* 
±1.15 
19.67* 
±3.51 
14.67 
±6.03 
13.67 
±3.51 
F 25.98 5.36 5.202 4.547 One way 
ANOVA P 0.000 0.008 0.009 0.0147 
*P<0.05, df (group)=5, n=3 in each group 
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3.2.2.4. Hemostatic activity: 
 
Purpose and rationale blood coagulation test: 
 
The coagulation cascade consists of a complex network of 
interactions resulting in thrombin-mediated cleavage of fibrinogen to 
fibrin which is one major component of a thrombus. The coagulation 
cascade can be initiated either by the “exogenous pathway”, the release of 
thromboplastin (tissue factor) leading to activation of factor VII to the 
tissue factor/factor VIIa complex, or by the “endogenous pathway”, so-
called contact activation leading via factors XII, XI and IX to the 
assembly of the tenase complex consisting of activated factors VIII and 
IX and Ca2+ on a phospholipids surface. Both complexes can activate 
factor X which induces the formation of the prothrombinase complex 
consisting of factor Xa, factor Va and Ca2+ on a phospholipid surface. 
The latter leads to the activation of thrombin which in turn cleaves 
fibrinogen to fibrin. The three coagulation tests (PT, APTT and TT) allow 
differentiating between effects on the exogenous or endogenous pathway 
or on fibrin formation. The influence of compounds on the plasmatic 
blood coagulation is determined by measuring the coagulation parameters 
prothrombin time (PT), activated partial thromboplastin time (APTT) and 
thrombin time (TT) ex vivo (11). 
 
Method of measurement of Hemostatic activity 
Rats were slightly ether anesthetized, and abdominal hair was 
carefully removed with electric clipper, they were fasted overnight. The 
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animals were divided into six groups of six rats in each. The animals of 
group I was left untreated and considered as control. The rats of Group II, 
III, IV, V, and VI were applied topically Karanj, medicated karanj oil, 
emulsion, microemulsion, and cream, respectively, on the abdominal area 
of 9 cm2 gently at a dose of 200 mg/kg (11). Rats were anesthetized by 
intravenous injection of 60 mg/kg sodium pentobarbital. The caudal caval 
vein was exposed by a mid-line incision and 1.8 ml blood were collected 
at 0 hr and 24 hrs into a plastic syringe containing 0.2 ml 100 mM citrate 
buffer pH 4.5. The sample was immediately agitated and centrifuged in a 
plastic tube at 1500 rpm for 10 min. Plasma was transferred to another 
plastic tube and the coagulation tests for the determination of 
thromboplastin time (PT), activated partial thromboplastin time (APTT) 
and thrombin time (TT) were performed within 3 h. In general, citrated 
plasma was coagulated by the addition of the respective compounds (see 
below for PT, APTT or TT) and the time in seconds to clot formation was 
determined in the coagulometer (12-13). 
 
Prothrombin Time (PT): An aliquot of 0.1 ml of citrated plasma was 
incubated for 1 min at 37°C. Then 0.2 ml of thromboplastin was added 
and the coagulometer was started. The time to clot formation was 
measured. The PT measures effects on the exogenous pathway of 
coagulation. 
 
Activated Partial Thromboplastin Time (APTT): To 0.1 ml of citrated 
plasma, 0.1 ml of placenta lipid extract was added and the mixture was 
incubated for 2 min at 37°C. The coagulation process was initiated by the 
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addition of 0.1 ml 25 mM calcium chloride when the coagulometer was 
started and the time to clot formation was determined. The APTT 
measures effects on the endogenous pathway of coagulation. 
 
Thrombin Time (TT): To 0.1 ml of citrated plasma, 0.1 ml of 
diethylbarbiturate-citrate buffer, pH 7.6 was added and the mixture was 
incubated for 1 min at 37 °C. Then 0.1 ml of bovine test-thrombin was 
added and the coagulometer was started. The time to clot formation was 
measured. The TT measures effects on fibrin formation. 
The mean values of PT, APTT, and TT were calculated and the 
results are presented in Table 3.11. 
 
Table 3.11: Results of Hemostatic Activity of Karanj oil 
Formulations 
PT  
(Seconds) 
APTT 
(Seconds) 
TT  
(Seconds) 
Animal Group 
Initial 24 hrs Initial 24 hrs Initial 24 hrs 
Group I 9.83 
±0.75
9.67 
±0.82 
29.16 
±1.17
28.83 
±1.33 
14.83 
±1.17 
15.17 
±1.17 
Group II 9.67 
±0.52
9.50 
±0.55 
28.00 
±0.89
27.50 
±1.05 
14.17 
±0.75 
14.00 
±0.63 
Group III 9.33 
±0.52
8.67 
±0.52 
27.17*
±0.75
27.00 
±0.89 
13.83 
±1.33 
13.66* 
±1.03 
Group IV 9.17
±0.75
8.83 
±0.41 
27.00*
±1.79
26.67* 
±1.37 
13.67 
±1.37 
13.17* 
±0.75 
Group V 9.00
±0.89
8.67 
±0.52 
27.17*
±0.75
26.50* 
±0.55 
13.83 
±1.33 
12.83* 
±0.75 
Group VI 9.17
±0.75
8.50* 
±0.55 
26.83*
±0.75
26.33* 
±1.03 
13.67 
±1.21 
13.00* 
±0.89 
One way F 1.242 4.356 4.000 4.488 0.8182 6.152 
ANOVA P 0.3145 0.0042 0.0067 0.0036 0.5464 0.0005 
P< 0.05, df=3, n=6 
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3.3. Results and Discussion 
 
3.3.1 Formulation Development of Karanj oil Emulsion: 
 
With an objective to fix oil phase concentration, emulsion of the 
karanj oil was prepared initially using gum acacia as a model emulsifier. 
The required quantity of karanj oil was weighed and transferred in a 
mortar. Weighted quantity of gum acacia were added in karanj oil with 
trituration. The measured volume of distilled water was added in portion 
with trituration. Remaining quantity of distilled water was added 
dropwise with trituration. The creamy slightly thick emulsion was 
obtained. The emulsion was evaluated for phase separation by 
centrifugation at 1500 RPM for 10 minutes in a glass test tube (15ml) and 
storing at RT overnight. The test tube containing the emulsion was gently 
inverted till homogenous emulsion was achieved and the number of 
inversions were counted in triplicate. The results of cream height and 
number of inversion for batch E1 to E5 were presented in Table 3.12.  
 
Table 3.12: Composition and results of evaluation parameters for 
emulsion containing Karanj oil and gum acacia 
Batch Code Ingredient 
(%w/w) E1 E2 E3 E4 E5 
Karanj oil 20 25 30 35 40 
Gum acacia 5 6.25 7.25 8.75 10 
Dist. Water q.s. to 100 100 100 100 100 
Parameters 
Creaming height Phase 
separation
5cm 1.3 cm 2.5cm 3.4 cm 
Number of 
inversion 
Not 
performed
Remained 
separated 
23 68 Thick 
cream 
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The results (Table 3.12) revealed that the emulsion containing 20% 
karanj oil (Batch E1) showed separation of oil phase on centrifugation, 
while the emulsion containing 25% karanj oil (Batch E2) showed cream 
height of 5 cm and emulsion containing 30% karanj oil (Batch E3) 
showed least phase separation (1.3cm). Emulsion of batch E3 was 
redispered evenly by 23 inversions, while of batch E4 by 68 inversions. 
The emulsion of Batch E5 was a thick cream, and it was not possible to 
redisperse it. Hence, 30% concentration of karanj oil (Batch E3) was 
selected for further studies of formulation optimization of emulsion. 
 
Formulation optimization of karanj oil emulsion using Tween 80 and 
Span 20 as emulsifiers: 
Externally used emulsions do not contained gum acacia as an 
emulsifying agent due to its stickiness and grittiness. Surfactants were 
widely used to increase dissolution and bioavailability of drug by 
lowering interfacial tension, which allowed better wetting and penetration 
of the drug from the dosage form. The combination of hydrophilic Tween 
80 with lipophilic Span 20 is widely preferred in formulation 
development of externally used emulsions by formulation pharmacist by 
varying the proportion as to produce o/w or w/o emulsion. When Tween 
80 is added, it orients at the interface such that part of its hydrocarbon tail 
is in the oil phase, and the remainder of the chain, together with the 
sorbitan ring and the polyoxyethylene chains, is located in the water 
phase, this orientation results in effective van der Waals attraction. The 
interfacial film is strengthened and the stability of o/w emulsion is 
increased against particle coalescence (14). To our knowledge, no 
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information is available on usage of combination of emulsifiers for 
formulation development of external application dosage form containing 
karanj oil. In the present study, the use of combination of Tween 80 and 
Span 20 as emulsifiers was explored in formulation development of 
karanj oil emulsion. On the basis of preliminary trials, emulsion 
containing karanj oil (30% w/w) and combination of Tween 80 and Span 
20 (10% and 5% w/w, respectively) were prepared.  
 
Experimental Design: 
To optimize the concentration of emulsifiers, a 32 factorial design 
was adopted using the concentration of Tween 80 (X1) and Span 20 (X2) 
as independent variables at three levels: low (-1), medium (0) and high 
(1). The composition of factorial design batches S1-S9 is presented in 
Table 3.3. The results of dependent variables such as cream height, 
number of inversions, and globule size of the batches S1 to S9 are shown 
in Table 3.13. 
 
Table 3.3: Composition of Batches of Factorial Design for Karanj 
oil Emulsion 
Batch Karanj Oil 
(%w/w) 
Tween 80  
(% w/w) 
Span 20  
(% w/w) 
S1 30 7.5 4 
S2 30 10 4 
S3 30 12.5 4 
S4 30 7.5 5 
S5 30 10 5 
S6 30 12.5 5 
S7 30 7.5 6 
S8 30 10 6 
S9 30 12.5 6 
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Table 3.13: Experimental Runs and the Measured Responses for 
Batches S1-S9 
Batch  X1 X2 Cream height, 
mm 
Number of 
Inversions 
Globule size, 
µm 
S1 -1 -1 31±3.6 21±3.6 34±3.0 
S2 0 -1 24±2.0 18±4.6 28±6.0 
S3 1 -1 17±2.0 13±2.0 24±3.6 
S4 -1 0 14±1.0 12±1.0 25±3.6 
S5 0 0 11±1.0 12±1.0 21±1.0 
S6 1 0 11±1.0 14±2.0 23±4.0 
S7 -1 1 14±1.0 16±1.0 28±5.0 
S8 0 1 11±1.0 19±2.0 30±50 
S9 1 1 10±1.0 25±3.0 29±4.0 
 
Factors and the levels in the experimental design    
Independent variables Levels 
 Low (-1) Medium (0) High (1) 
Tween 80 (X1), % 7.5 10 12.5 
Span 20 (X2), % 4 5 6 
 
Response surface curvature can be examined when the two 
variables are investigated at three levels. The design provided the 
following emperical second-order equation (Full model). 
 
Y = b0 + b1X1 + b2X2 + b12X1X2 + b11X12 + b22X22            (Eq. 3.1) 
 
where Y is response, b0 is intercept, b1 and b2 are coefficients of main 
effects, b12 is the coefficient for the interaction term and b11 and b22  are 
the coefficients for the second-order quadratic terms. The non-significant 
estimated coefficients should be dropped from the full model by adopting 
a significance test for the regression coefficient. Microsoft Excel® was 
used to identify non-significant terms. A coefficient is significant if t i > 
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tcrit (v), where v is the degrees of freedom of residual variance. The refined 
model may be used for calculation of residuals or for drawing the contour 
plot. The full and refined models (p < 0.05) of factorial design batches S1-
S9 for cream height, number of inversions, and globule size are shown in 
Table 3.14. 
 
Table 3.14: Summary of Results of Regression Analysis for Batches 
S1-S9 
Response  b0 b1 b2 b11 b22 b12 r2 
FM 11.44 -3.50 -6.17 0.83 5.83 2.5 0.9688 Cream 
height, 
mm 
RM 12.00 -3.50 -6.17 - 5.83 - 0.9042 
FM 12.33 0.50 1.33 0.50 6.00 4.25 0.9807 Number 
of 
inversions
RM 12.67 0.50 1.33 - 6.00 4.25 0.9776 
FM 22.44 -1.83 0.17 0.83 5.83 2.75 0.9125 Globule 
size, µm RM 23.00 -1.83 0.17 - 5.83 2.75 0.9205 
FM = Full model, RM = Refined model 
 
Cream height: The refined model showed that the second-order term, 
b11, and interaction term, b12, were insignificant.  The P value was found 
to be close to 0.03 for the second order term (X22). It was concluded that 
the coefficients, b1 and b2, carry a negative sign and therefore addition of 
each surfactant can decrease the cream height of the emulsion. The lowest 
cream height was observed when both the emulgent were used at medium 
levels. The poor emulsion stability may be attributed to poor 
emulsification and wetting when emulgent was used at low level. The 
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relationship between X1, X2 and cream height is diagrammatically shown 
in Fig. 3.7. The improved emulsion stability at medium levels of 
emulgent is attributed to improved emulsification of karanj oil using 
combination of emulsifiers. 
 
Figure 3.7: Contour Plot for Cream Height for Batches S1-S9 
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Number of Inversions: A coefficient with positive sign shows a 
synergistic effect whereas a coefficient with a negative sign shows an 
antagonistic effect. The regression coefficients b22 and b12 were found to 
be significant. Hence, conclusions should not be drawn by considering 
the mathematical signs of the main effects b1 and b2. Figure 3.8 showed 
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the contour plot for number of inversions. Tween 80 and Span 20 are 
nonionic surfactant; Tween 80 is hydrophilic, while Span 20 is lipophilic. 
The hydrophilic or lipophilic characteristics of the emulsifying agents 
adversely affected the number of inversions, especially at medium levels. 
It was worth noting that a low level of emulgent did not exhibit an 
appreciable improvement in redispersibility. However, one can conclude 
that the all nine batches showed acceptable redispersibility (Table 3.13). 
The final selection of the batch was done after considering the other 
requirements of the dosage form, i.e. cream height, globule size, etc.  
 
Figure 3.8: Contour Plot for Number of Inversions for Batches S1-S9 
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Globule size: 
The refined model indicates that only the second-order terms (b11) is 
insignificant.  Tween 80 seems to be more effective in controlling globule 
size since the coefficient b1 (-1.83) is greater in magnitude compared with 
the coefficient b2 (0.17). The HLB value of Tween 80 is 15 and Span 20 
is 4.5. The lower the HLB number, more lipophilic the compound and 
vice versa. The non-significant interaction term indicated that Tween 80 
did not affect the functionality of Span 20. The contour plot (Fig. 3.9) 
showed that lower values of globule size can be obtained even at high to 
medium level of X1. The plot indicates that to obtain globule size of 22 µ, 
at least a medium level of X2 is required. 
 
Figure 3.9: Contour Plot for Globule Size for Batches S1-S9 
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To validate the evolved mathematical models (reduced models for 
cream height, number of inversions, and globule size), two check point 
batches (C1 and C2) were prepared and evaluated. The observed and 
predicted values are shown in Table 3.15. Good correlation was found 
between observed and predicted values. Hence, it may be concluded that 
the evolved models may be used for theoretical prediction of responses 
within the factor space. 
 
 
Table 3.15: Observed and Predicted Results of Check points for 
Karanj oil Emulsion 
Batch C1  
(X1 = 0, X2 = 0.5) 
Batch C2  
(X1 = -0.2, X2 = 0) 
Response 
Observed Predicted Observed Predicted
Cream height, mm 10.67 10.37 13.00 12.70 
Number of Inversions 15.33 14.83 12.33 12.57 
Globule size, µm 25.00 24.54 24.33 23.60 
 
The following constraints were arbitrarily used for the selection of 
an optimized batch: Cream height < 15 mm, Number of inversions < 13, 
and Globule size < 25 µm. The batch S5 met these selection criteria. 
 
The batch S5 showed the lowest cream height and globule size 
among the factorial design batches and hence it was considered as the 
optimized formulation of karanj oil emulsion in the present study. 
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3.3.2 Formulation development of Microemulsion of Karanj Oil: 
 
The concept of microemulsion was introduced by Hoar and 
Schulman in 1943 (15). They prepared the first microemulsions by 
dispersing oil in an aqueous surfactant solution and adding an alcohol as a 
co-surfactant, leading to a transparent, stable formulation. The existence 
of this theoretical structure was later confirmed by use of various 
technologies, and it is defined by Attwood (16) as “a microemulsion is a 
system of water, oil, and amphiphilic compounds (surfactant and co-
surfactant) which is a transparent, single optically isotropic, and 
thermodynamically stable liquid”.  
 
These dispersed systems are isotropic, as opposed to liquid crystals 
which are anisotropic. The main difference between emulsion and 
microemulsion lies in the size and shape of the particles dispersed in the 
continuous phase: these are at least an order of magnitude smaller in the 
case of microemulsions (10–200 nm) than those of conventional 
emulsions (1–30 μm). Emulsions consist of roughly spherical droplets of 
one phase dispersed into the other, microemulsions constantly evolve 
between various structures ranging from droplet like swollen micelles to 
bicontinuous structures, making the usual o/w and w/o.  Microemulsions 
are formed when and only when the interfacial tension at the oil/water 
interface is brought to a very low level and the interfacial layer is kept 
highly flexible and fluid. These two conditions are usually met by a 
careful and precise choice of the components and of their respective 
proportions, and by the use of a co-surfactant which brings flexibility to 
the oil/water interface. These conditions lead to a thermodynamically 
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optimized structure, which is stable as opposed to conventional emulsions 
and does not require high input of energy (i.e. through agitation) to be 
formed. As the size of the particles is much smaller than the wavelength 
of visible light, microemulsions are transparent and their structure cannot 
be observed through an optical microscope. 
 
In topical formulations, microemulsions have been proved to 
increase the cutaneous absorption of both lipophilic and hydrophilic 
API’s when compared to conventional vehicles (emulsions, pure oils, 
aqueous solutions, etc.). Many topical formulations currently marketed 
are based on microemulsions.  
 
Figure 3.10: Structure of Microemulsion 
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Formulation optimization of microemulsion of Karanj oil: 
The main problem in microemulsion formulations is to identify 
surfactant combinations that would produce a thermodynamically stable 
formulation. It is essential to establish the phase behavior of the particular 
combination of chosen components. The formulation of microemulsions 
is still highly empirical and time consuming and full characterization of 
such systems is a tedious task and requires a large number of 
experiments. Accordingly, the aim of the present study was to develop 
microemulsion formulations using experimental design which may 
bypass the need to study the phase behavior of microemulsion systems 
and thus minimize the experimental efforts using desirability function. 
To our knowledge, no information is available on usage of 
combination of co-surfactant, surfactant, and solubilizer for the 
formulation development of external application dosage form containing 
karanj oil. In the present study, the use of combination of Glyceryl 
dilaurate, Cremophor RH 40, and Transcutol P as co-surfactant, 
surfactant, and solubilizer respectively was explored in formulation 
development of karanj oil microemulsion. On the basis of preliminary 
trials, microemulsions containing karanj oil (15% w/w) and combination 
of Glyceryl dilaurate, Cremophor RH 40, and Transcutol P (10%, 20% 
and 10% w/w, respectively) were prepared using distilled water. 
 
Experimental Design: 
To optimize the concentration of co-surfactant, surfactant, and 
solubilizer, a 33 factorial design was adopted using the concentration of 
Glyceryl dilaurate  (X1), Cremophor RH 40 (X2), and Transutol P (X3) as 
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independent variables at three levels: low (-1), medium (0) and high (1). 
The factorial design batches F1-F27 were prepared and their composition 
is presented in Table 3.5. The results (n=3) of dependent variables such as 
Viscosity (cp), globule size (nm), and Zeta potential (mV) of the batches 
F1 to F27 are shown in Table 3.16. 
Table 3.5: Composition of Batches of Factorial Design for Karanj oil 
Microemulsion 
Batch Karanj Oil 
(%w/w) 
Glyceryl dilaurate 
(% w/w) 
Cremophor 
RH 40 (% w/w) 
Transcutol 
(% w/w) 
F1 15 7.5 17.5 7.5 
F2 15 7.5 20 7.5 
F3 15 7.5 22.5 7.5 
F4 15 10 17.5 7.5 
F5 15 10 20 7.5 
F6 15 10 22.5 7.5 
F7 15 12.5 17.5 7.5 
F8 15 12.5 20 7.5 
F9 15 12.5 22.5 7.5 
F10 15 7.5 17.5 10 
F11 15 7.5 20 10 
F12 15 7.5 22.5 10 
F13 15 10 17.5 10 
F14 15 10 20 10 
F15 15 10 22.5 10 
F16 15 12.5 17.5 10 
F17 15 12.5 20 10 
F18 15 12.5 22.5 10 
F19 15 7.5 17.5 12.5 
F20 15 7.5 20 12.5 
F21 15 7.5 22.5 12.5 
F22 15 10 17.5 12.5 
F23 15 10 20 12.5 
F24 15 10 22.5 12.5 
F25 15 12.5 17.5 12.5 
F26 15 12.5 20 12.5 
F27 15 12.5 22.5 12.5 
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Table 3.16: Experimental Runs and Measured Responses for 
Karanj oil Microemulsion Batches F1 to F27 
Run No. X1 X2 X3 Viscosity 
(cp) 
Globule size 
(nm)  
Zeta potential
(mV) 
F1 -1 -1 -1 112.12±1.90 116.03±4.02 -11.23±1.21 
F2 -1 0 -1 111.45±0.77 112.95±4.73 -14.34±1.35 
F3 -1 1 -1 108.32±2.24 108.44±2.88 -17.93±1.74 
F4 0 -1 -1 108.76±1.45 98.37±2.04 -19.42±0.18 
F5 0 0 -1 106.44±3.87 88.54±5.64 -22.21±2.46 
F6 0 1 -1 105.34±6.77 87.21±5.46 -24.45±2.17 
F7 1 -1 -1 110.96±1.09 93.36±2.97 -23.95±1.26 
F8 1 0 -1 98.23±2.22 78.86±5.37 -27.15±0.82 
F9 1 1 -1 95.36±3.88 74.22±2.09 -25.32±2.09 
F10 -1 -1 0 93.82±4.83 71.31±3.23 -29.43±2.90 
F11 -1 0 0 91.64±1.30 65.66±2.56 -22.54±3.38 
F12 -1 1 0 93.21±3.82 64.82±3.11 -26.65±3.24 
F13 0 -1 0 91.36±2.98 59.02±5.85 -29.14±3.20 
F14 0 0 0 87.33±5.59 58.62±3.92 -30.16±3.67 
F15 0 1 0 85.52±0.81 54.48±4.06 -30.24±3.30 
F16 1 -1 0 84.14±2.29 52.56±2.55 -36.34±1.75 
F17 1 0 0 77.33±5.10 55.62±2.13 -34.45±5.39 
F18 1 1 0 79.45±0.78 45.11±2.10 -38.54±2.00 
F19 -1 -1 1 83.21±2.12 48.09±3.91 -41.65±2.78 
F20 -1 0 1 85.85±3.03 51.33±4.23 -36.92±4.22 
F21 -1 1 1 87.33±1.27 48.65±4.37 -39.38±4.91 
F22 0 -1 1 77.04±3.37 47.12±4.88 -36.55±7.88 
F23 0 0 1 83.31±2.11 52.92±2.34 -44.26±2.08 
F24 0 1 1 84.25±2.06 55.48±1.20 -45.04±3.59 
F25 1 -1 1 82.05±2.52 58.31±5.15 -43.91±8.16 
F26 1 0 1 82.93±1.89 63.43±2.78 -44.84±6.00 
F27 1 1 1 80.07±2.44 62.93±2.10 -45.06±3.71 
  Factors and the levels in the design 
Levels Independent variables Low (-1) Medium (0) High (1)
Glyceryl dilaurate (X1), %w/w 7.5 10 12.5 
Cremophor RH 40 (X2), %w/w 17.5 20 22.5 
Transcutol (X3), %w/w 7.5 10 12.5 
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Response surface curvature can be examined when the variables 
are investigated at three levels. The design provides the following 
emperical second-order equation (Full model, FM): 
 
Y = b0 + b1X1 + b2X2 + b3X3 + b11 X12 + b22 X22 + b33 X32 +b12 X1X2 + 
b23X2X3 + b13X1X3 + b123X1X2X3              (Eq. 3.2) 
 
where Y is response, b0 is the intercept, b1, b2 and b3 are regression 
coefficient of main effects and b12, b23, b13 and b123 are regression 
coefficient for the interaction terms. The coefficients with second-order 
terms (b11, b22 and b33) indicate the quadratic nature. Microsoft Excel® 
may be used to identify the non-significant terms. The refined model 
(RM) may be used for calculation of residuals or for drawing contour 
plots. The full and refined models (p < 0.05) for Viscosity (cp), globule 
size (nm), and Zeta potential (mV) are shown in Table 3.17. 
 
Table 3.17: Summary of Results of Regression Analysis for Karanj 
oil Microemulsion Batches F1 to F27 
 Viscosity (cp) Globule size (nm)  Zeta potential (mV)
 FM RM FM RM FM RM 
b0 86.64 87.09 56.44 56.05 -30.57 -31.16 
b1 -4.25 -4.25 -5.72 -5.72 -4.42 -4.42 
b2 -1.37 -1.37 -2.34 -2.38 -1.17 -1.17 
b3 -12.66 -11.72 -20.54 -20.54 -9.96 -10.65 
b11 -0.068 - 3.787 3.787 0.184 - 
b22 0.738 - -0.575 - -0.583 - 
b33 7.52 7.52 16.21 16.21 -0.479 - 
b12 -1.83 -1.83 -0.704 - -0.256 - 
b23 2.68 2.68 4.286 4.286 0.478 - 
b13 1.41 - 10.63 10.63 -1.03 - 
b123 0.712 - 1.95 - -1.09 - 
r2 0.9599 0.9555 0.9859 0.9827 0.9505 0.9423 
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The results of regression analysis (Table 3.17) revealed that the 
sign of main effects, i.e. b1, b2, and b3 is negative which indicated that 
addition of Glyceryl dilaurate, Cremophor, and Transcutol P decreased 
the viscosity, globule size, and Zeta potential of the formulations. The 
value of regression coefficient is nearer to 0.99 which indicated the good 
correlation among the results. 
 
Desirability function approach 
Process and product optimization are common objectives in 
industrial research. The overall quality of a product can be defined by 
many performance characteristics which are commonly referred as 
responses in the statistical literatures. Often a decision maker is faced 
with the problem of balancing one response against the other. The 
decision maker must weigh each response according to their relative 
importance and compromise when these responses are in opposition in 
order to achieve the most desirable or optimum solution (17).  
Desirability function approach is powerful tools for solving the 
multiple performance characteristics optimization problems, where all the 
objectives are to attain a definite goal simultaneously. The basic idea of 
the approach is to convert a multiple performance characteristics 
optimization problem into a single response optimization problem with 
the objective function of overall desirability. The general approach is to 
first convert each response, yi, into an individual desirability function, di, 
that may vary over the range 0 ≤ di ≤1, where if the response Yi meets the 
goal or target value T, then di = 1; and if the response falls beyond the 
acceptable limit T, then di = 0. The target T is located between the lower 
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L and upper U limits. The next step is to select the parameter combination 
that will maximize overall desirability D using equations mentioned as 
under: 
D = (d1.d2.d3….dm)1/m                          (Eqn. 3.3)                   
where, m= number of responses. 
The individual desirability functions are calculated by equations shown 
below:  
If the objective or target T for the response Y is a maximum value, 
D = 0, if y < L, 
D = 
r
LT
LY ⎟⎠
⎞⎜⎝
⎛
−
− , L ≤ Y ≤ T,                                (Eqn. 3.4) 
D = 1, if Y>T. 
When the weight r =1, the desirability function is linear. Selecting r>1 
places more emphasis on being close to the target value, and selecting 0<r 
<1 makes this less important. 
If the target T for the response Y is a minimum value, 
D = 1, if y < T, 
D = 
r
TU
YU ⎟⎠
⎞⎜⎝
⎛
−
− , T ≤ Y ≤ U,                                (Eqn. 3.5) 
D = 0, if Y> U. 
 
For optimization of the microemulsion formulation using 33 
factorial design, the parameters such as viscosity and globule size are to 
be minimized, while zeta potential is to be optimized. First of all, the 
individual desirability is calculated as per the equations 3.5 and shown in 
the Table 3.18. The most acceptable dimensions for viscosity, globule 
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size, and zeta potential have been chosen as 77.33, 45.11 and - 45.06 
respectively. The overall desirability value have been calculated by using 
equation 3.3 and shown in the Table 3.18. 
 
Table 3.18: Desirability values for Responses for Batches F1 to F27 
Run 
No. 
Viscosity 
(cp) 
Globule 
size 
(nm)  
Zeta 
potential 
(mV) 
DVS DGS DZP DOV 
F1 112.12 116.03 -11.23 0.0000 0.0000 0.0000 0.0000 
F2 111.45 112.95 -14.34 0.0193 0.0434 0.0919 0.0425 
F3 108.32 108.44 -17.93 0.1092 0.1070 0.1980 0.1323 
F4 108.76 98.37 -19.42 0.0966 0.2490 0.2421 0.1799 
F5 106.44 88.54 -22.21 0.1633 0.3876 0.3246 0.2739 
F6 105.34 87.21 -24.45 0.1949 0.4064 0.3908 0.3140 
F7 110.96 93.36 -23.95 0.0333 0.3197 0.3760 0.1588 
F8 98.23 78.86 -27.15 0.3993 0.5241 0.4706 0.4618 
F9 95.36 74.22 -25.32 0.4817 0.5895 0.4165 0.4909 
F10 93.82 71.31 -29.43 0.5260 0.6306 0.5380 0.5630 
F11 91.64 65.66 -22.54 0.5887 0.7102 0.3343 0.5190 
F12 93.21 64.82 -26.65 0.5435 0.7221 0.4558 0.5635 
F13 91.36 59.02 -29.14 0.5967 0.8039 0.5294 0.6333 
F14 87.33 58.62 -30.16 0.7126 0.8095 0.5596 0.6860 
F15 85.52 54.48 -30.24 0.7646 0.8679 0.5619 0.7198 
F16 84.14 52.56 -36.34 0.8043 0.8950 0.7422 0.8114 
F17 77.33 55.62 -34.45 1.0000 0.8518 0.6864 0.8362 
F18 79.45 45.11 -38.54 0.9391 1.0000 0.8073 0.9118 
F19 83.21 48.09 -41.65 0.8310 0.9580 0.8992 0.8945 
F20 85.85 51.33 -36.92 0.7551 0.9123 0.7594 0.8058 
F21 87.33 48.65 -39.38 0.7126 0.9501 0.8321 0.8259 
F22 77.04 47.12 -36.55 1.0083 0.9717 0.7484 0.9018 
F23 83.31 52.92 -44.26 0.8281 0.8899 0.9764 0.8961 
F24 84.25 55.48 -45.04 0.8011 0.8538 0.9994 0.8809 
F25 82.05 58.31 -43.91 0.8643 0.8139 0.9660 0.8792 
F26 82.93 63.43 -44.84 0.8390 0.7417 0.9935 0.8519 
F27 80.07 62.93 -45.06 0.9212 0.7487 1.0000 0.8836 
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As per the desirability function approach, it converts multiple 
objectives into a single objective function. This objective function is 
called as overall desirability function. To get an optimum process 
condition, the overall desirability is being optimized. The results of the 
Table 3.18 revealed that the maximum D value for viscosity (DVS) is 1 for 
batch F17, for globule size (DGS) is 1 for batch F18, and for zeta potential 
(DZP) is 1 for batch F27. On the basis of individual microemulsion 
characteristics, the respective batches may be considered as optimized for 
the respective parameters. The overall desirability D value (DOV) for 
batch S18 is 0.9118 which is maximum. Hence on the basis of overall 
optimum characteristics, the batch F18 may be considered as optimized 
batch in microemulsion formulation prepared using glyceryl dilaurate, 
Cremophor RH 40, and Transcutol P. It was concluded that with a 
minimum number of experimental runs, the desirability function 
approach is a quite efficient one for solution of optimization problem in 
microemulsion formulation. 
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3.3.3 Wound healing activity of Karanj oil Formulations: 
 
The results of wound healing activity (Table 3.8) were expressed as 
mean ± standard deviation of six animals in each group. The data were 
statistically evaluated by one-way ANOVA followed by Tukey’s pair-
wise comparison test. The values of p<0.05 were considered as 
statistically significant. The histogram of wound healing activity of 
Karanj oil and its formulations is presented in Figure 3.11. 
 
Fig.3.11: Histogram of Wound Healing Efficiency of Karanj oil 
Formulations 
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In studies of assessment of cutaneous wound healing activity using 
excision wound model (Table 3.8 and Fig. 3.11), the rats treated with 
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cream containing 1% w/w framycetin sulphate showed wound healing 
area of 283.89±19.42 mm2 on initial day and 17.04±5.67 mm2 on 16th day. 
The karanj oil treated group III and medicated karanj oil treated group IV 
showed wound healing area of 144.53±41.77 mm2 and 126.15±27.88 
mm2 on 16th day as compared to untreated control animals (180.39±11.55 
mm2 on 16th day). The wound healing area of 45.78±12.77 mm2, 
10.53±1.88 mm2, and 16.71±3.62 mm2 on 16th day was exhibited by 
emulsion treated group V, microemulsion treated group VI, and cream 
treated group VII, respectively. 
 
Wound healing Activity Groups 
Group I Untreated (Control) 
Group II Standard (1% Framycin) 
Group III Karanj Oil 
Group IV Medicated Karanj oil 
Group V Emulsion (30% Karanj oil) 
Group VI Microemulsion (15% Karanj oil) 
Group VII Cream (30% Karanj oil)  
 
The one-way ANOVA results for wound healing activity (Fig.3.12) 
showed that the p value for Turkey’s pair wise comparison test for wound 
healing at 0 day for group II to VII were 0.9967, 0.9566, 0.9864, 0.9998, 
0.9999, and 0.9990 respectively with reference to group I, where all p 
values were greater than 0.05 (p>0.05) which indicated that the results of 
wound healing at 0 day were similar. The p value for wound healing at 4 
day (Fig.3.13) for the group III and IV were 0.3435 and 0.1315 with 
reference to group I, which were greater than 0.05 (p>0.05) which 
indicated that the results are non-significant meaning no difference in the 
wound healing activity. But for group II, V, VI, and VII, the p value was 
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0.0001 which is smaller than 0.05 indicated that the results of activity 
were significant meaning the difference in the activity with reference to 
group I.  
Fig.3.12: One-way ANOVA Results of Wound Healing Activity at 0 
day of Karanj oil Formulations 
 
 
Fig.3.13: One-way ANOVA Results of Wound Healing Activity at 4 
day of Karanj oil Formulations 
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The One-way ANOVA results of wound healing at 8 day 
(Fig.3.14) and 16 day (Fig.3.15), the p value for the group III were 
0.0528 and 0.0572 respectively with reference to group I which was 
greater than 0.05 indicated that the difference is non-significant meaning 
no difference in the wound healing activity. For group II, V, VI, and VII, 
the p value was 0.0001 which is <0.05 indicated that the results of wound 
healing activity at 8 day and 16 day were significant meaning the 
difference in the activity with reference to group I. The p value less than 
0.05 indicated that the karanj oil formulations showed significant wound 
healing activity. 
 
Fig.3.14: One-way ANOVA Results of Wound Healing Activity at 8 
day of Karanj oil Formulations 
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Fig.3.15: One-way ANOVA Results of Wound Healing Activity at 16 
day of Karanj oil Formulations 
 
 
The results of Table 3.8 revealed that the standard drug treated 
animal group II (94.00%) showed significantly greater % wound closure 
as compared to control group I (37.64%) and karanj oil treated group III 
(51.51%) on 16 day. The animal group IV treated with medicated karanj 
oil showed 57.42% wound closure on 16 day. The animal group V treated 
with emulsion of karanj oil showed 84.34% wound closure on 16 day. 
The animal group VI and VII treated respectively with microemulsion 
and cream of karanj oil showed 96.32% and 94.13% wound closure on 16 
day which comparable with that of standard group II. 
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The period of epithelialisation was 19.33 ± 1.21 days in the case of 
standard drug treated animal group II (1% w/w framycetin sulphate 
cream). The period of epithelialisation was 32.17±3.06 days for untreated 
group I, while same was 27.83±1.47 and 25.67±2.58 days for karanj oil 
group III and medicated karanj oil treated group IV respectively. The 
period of epithelialisation was 21.50±1.87, 17.67±0.52, and 18.50±1.05 
days for emulsion treated group V, microemulsion treated group VI, and 
cream treated group VI respectively.   For group II, V, VI, and VII, the p 
value was 0.0001 which is <0.05 indicated that the one-way ANOVA 
results of period of epithelialisation (Fig.3.16) were significant meaning 
the difference in the activity with reference to group I. The results of the 
wound healing activity revealed that the significant promotion of wound 
healing was observed by karanj oil and its formulations as compared to 
control group. 
 
Fig.3.16: One-way ANOVA Results of Period of Epithelialisation of 
Karanj oil Formulations 
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3.3.4 Antimicrobial activity of Karanj oil Formulations: 
 
All the experimentation of antibacterial activity was carried out in 
aseptic area under laminar air-flow cabinet. The results of antibacterial 
activity of the positive control i.e. 1% w/w framycin cream, karanj oil and 
medicated karanj oil, formulations of karanj oil (Emulsion, 
Microemulsion and cream) were presented in Table 3.10. The comparison 
of the antibacterial activity of oils with the standard drug was presented in 
Fig. 3.17. Sterilized distilled water was served as negative control. 1gm 
of 1% W/W framycetin sulphate cream (FSC) ointment diluted and mixed 
with 9ml of sterilized distilled water was used as standard i.e. positive 
control. 
 
Fig. 3.17: Histogram of Antibacterial Activity of Karanj Oil 
Formulations 
0
5
10
15
20
25
30
35
40
B.Subtilis S.Aureus E.Coli S.Typhi
Zo
ne
 o
f I
nh
ib
iti
on
 in
 m
m
Positive
Karanj oil
Med KO
Emulsion
Microemulsion
Cream
 
 
 
 
 
Wound Healing, Antimicrobial & Hemostatic activity of Karanj Oil & its 
Formulations 
 
                                                                                                                                 124 
The karanj oil was found to be most inhibitory against S. aureus 
(14.33±4.16), the least inhibition by karanj oil was found against S. 
subtilis (10.33±1.53). The medicated karanj oil was found to be most 
inhibitory against S. aureus (19.33±4.73), the least inhibitory against S. 
typhi (11.67±4.04). The zone of inhibition for emulsion, microemulsion 
and cream of karanj oil was 15.33±3.51, 17.67±5.03, and 13.67±3.51 mm 
respectively against S. typhi. The results revealed that karanj oil and its 
formulations exhibited significant antibacterial activity. 
Fig.3.18: One-way ANOVA Results of Antibacterial Activity against 
B. subtilis of Karanj oil Formulations 
 
Fig.3.19: One-way ANOVA Results of Antibacterial Activity against 
S. Aureus of Karanj oil Formulations 
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Fig.3.20: One-way ANOVA Results of Antibacterial Activity against 
E. Coli of Karanj oil Formulations 
 
 
Fig.3.21: One-way ANOVA Results of Antibacterial Activity against 
S. Typhi of Karanj oil Formulations 
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The one-way ANOVA results showed that the p value for Turkey’s 
pairwise comparison test for antibacterial activity against B. Subtilis (Fig. 
3.18) for karanj oil, medicated karanj oil, emulsion, microemulsion and 
cream of karanj oil was 0.0002, 0.0002, 0.0003, 0.0157, and 0.0002 
respectively which is <0.05 indicated that the results of antibacterial 
activity against B. Subtilis were significant meaning the difference in the 
activity with reference to negative control. Similarly, the results of   one-
way ANOVA for S. aureus, E. coli, and S. typhi (Fig. 3.19-3.21) 
indicated significant antibacterial activity of karanj oil formulations. The 
p value less than 0.05 indicated that the karanj oil formulations showed 
significant antibacterial activity. 
 
Microbial infection of wounds delays healing (1) and causes a 
more pronounced acute inflammatory reaction (2) which can lead to 
further tissue injury and damage. The antimicrobial activity of honey and 
the essential oil of Melaleuca alternifolia reported to underlie their 
usefulness as alternative therapy in wound healing (3). Thus, the 
antimicrobial activity of karanj oil and its formulations on these wound 
isolates may partly contribute to the wound healing effect by eliminating 
infection thus allowing the natural tissue repair processes to start. It can 
also be concluded that the karanj oil may also play a useful role in 
accelerating the healing of old wounds by eradicating already established 
infection.  
 
 
 
 
Wound Healing, Antimicrobial & Hemostatic activity of Karanj Oil & its 
Formulations 
 
                                                                                                                                 127 
3.3.5 Hemostatic activity of Karanj oil Formulations: 
 
Influence of karanj oil on PT  
 
The test measures the clotting time of plasma in the presence of an 
optimal concentration of tissue extract (thromboplastin) and indicate the 
overall efficiency of the extrinsic clotting system (Factors II, V, VII and 
X). The test is also known to depend on reactions with factors V, VII and 
X, and on the fibrinogen concentration of the plasma. The coagulation 
process is triggered by incubation of plasma with the optimal amount of 
thromboplastin and calcium. The time to formation of a fibrin clot is then 
measured.  
 
It can be seen from Table 3.11 that the medicated karanj oil 
application resulted sight change in prothrombin time (9.33± 0.52 secs at 
initial and 8.67±0.52 secs at 24 hrs) as compared to karanj oil (9.67±0.52 
secs at initial and 9.50±0.55 secs at 24 hrs) and control group (9.83±0.75 
secs at initial and 9.67±0.82 at 24 hrs).  The prothrombin time for animals 
treated with emulsion, microemulsion, and cream formulations of karanj 
oil was 8.83±0.41, 8.67±0.52, and 8.50±0.55 at 24 hrs respectively. 
 
Influence of karanj oil on APTT  
The test measures the clotting time of plasma after the activation of 
contact factors but without added tissue thromboplastin, and so indicates 
the overall efficiency of the intrinsic pathway (Factors VIII and IX as 
well as the contact factors). Incubation of plasma with the optimal 
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quantity of phospholipids and a surface activator leads to activation of 
factors of the intrinsic coagulation system. The addition of calcium ions 
trigger the coagulation process, the time to formation of a fibrin clot is 
measured.  
APTT for control group was 29.16±1.17 and 28.83±1.33 secs at 
initial and at 24 hrs respectively. APTT was shortened after the medicated 
karanj oil application to 27.17 ± 0.75 seconds at initial and 27.00±0.89 at 
24 hrs (Table 3.11 and Figure 3.22) as compared to the control group 
(29.16±1.17 secs at initial and 28.83±1.33 secs at 24 hrs) and karanj oil 
(28.00±0.89 secs at initial and 27.50±1.05 secs at 24 hrs). Similarly, the 
application of emulsion, microemulsion, and cream resulted in slight 
shortening of APTT to 26.67±1.37, 26.50±0.55, and 26.33±1.03 secs at 
24 hrs in the present study.  
 
Fig. 3.22: Curve of Hemostatic activity of Karanj oil formulations 
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Influence of karanj oil on TT 
 
TT was shortened after the medicated karanj oil application to 
13.83±1.33 seconds at initial and 13.66±1.03 at 24 hrs (Table 3.11 and 
Figure 3.13) as compared to the control group (14.83±1.17 secs at initial 
and 15.17±1.17 secs at 24 hrs) and karanj oil (14.17±0.75 secs at initial 
and 14.00±0.63 secs at 24 hrs). The TT was slightly shortened on the 
application of emulsion, microemulsion, and cream to 13.17±0.75, 
12.83±0.75, and 13.00±0.89 secs at 24 hrs in the present investigation. 
 
 The results of present investigation indicated that the karanj oil had 
shortened the PT, APTT and TT indicating its hemostatic activity. 
  
3.4. Conclusions  
 
The wound healing activity of Karanj oil and its formulations was 
studied by using excision wound model and significant wound healing 
activity was observed. The seed oil of Karanj tree inhibited microbial 
growth of known wound contaminants and accelerated wound healing 
process. It also exhibited hemostatic activity with accelerated blood 
coagulation process. The wound healing, antimicrobial and hemostatic 
activity are interrelated. The results of the present study indicated that 
karanj oil had good potentials for use in wound care and further provided 
a rationale for the use of the plant in wound management in traditional 
medicine practice. 
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In addition to inhibiting the growth of the micro-organisms and 
shortening the blood coagulation time, the karanj oil effectively reduced 
the epithelialisation period of experimentally-induced wounds which is an 
index of pro-healing activity. The precise aspect as well as the exact 
mechanism of wound healing effect of the karanj oil is yet to be 
elucidated with respect to antimicrobial as well as hemostatic activity. In 
the tissue repair process, inflammatory cells promote the migration and 
proliferation of endothelial cells, leading to neovascularisation of 
connective tissue cells which synthesize extracellular matrices including 
collagen, and of keratinocytes resulting to re-epithelialisation of the 
wounded tissue (18). In the wound healing process, collagen formation 
peaks at day 7 and epithelialisation occurs in 48 hrs under optimal 
conditions (19). The extent to which the karanj oil and its formulations 
interacted with these processes is not known to us and it needs to be 
clinically investigated systematically and scientifically. 
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Summary 
 
The local name of the oil of Derris Indica is Karanj oil. Medicated 
karanj oil is used widely by Ayurvedic Practitioners in rural areas of 
Gujarat for the treatment of rheumatism and curing skin infections. It is 
used for healing, antiseptic, and haemostatic effect externally by 
Ayurvedic Practitioners.  
 
Systemic information is not available on the efficacy of karanj oil. 
The present investigation was aimed to study systematically and 
scientifically the efficiency of Karanj oil. The formulations of the karanj 
oil were prepared using pharmaceutical methodology. The activity of the 
karanj oil, medicated karanj oil, selected optimized formulation of 
emulsion, microemulsion and cream of karanj oil was studied for wound 
healing, antibacterial, and haemostatic efficiency. 
 
Formulation optimization: 
 
Emulsion of karanj oil: 
To optimize the concentration of emulsifiers for emulsion of karanj 
oil, a 32 factorial design was adopted using the concentration of Tween 80 
(X1) and Span 20 (X2) as independent variables at three levels: low (-1), 
medium (0) and high (1). The factorial design batches were prepared by 
dry gum method. The dependent variables were cream height, number of 
inversions, and globule size. Response surface curvature can be examined 
when the two variables are investigated at three levels. The design 
provided the following emperical second-order equation (Full model): 
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Y = b0 + b1X1 + b2X2 + b12X1X2 + b11X12 + b22X22 
 
where Y is response, b0 is intercept, b1 and b2 are coefficients of main 
effects, b12 is the coefficient for the interaction term and b11 and b22  are 
the coefficients for the second-order quadratic terms. The non-significant 
estimated coefficients should be dropped from the full model by adopting 
a significance test for the regression coefficient. Microsoft Excel® was 
used to identify non-significant terms. A coefficient is significant if t i > 
tcrit (v), where v is the degrees of freedom of residual variance. The refined 
model may be used for calculation of residuals or for drawing the contour 
plot. The full and refined models (p < 0.05) of factorial design batches for 
cream height, number of inversions, and globule size were obtained and 
contour plots were constructed.  
 
To validate the evolved mathematical models (reduced models for 
cream height, number of inversions, and globule size), two check points 
were prepared and evaluated. Good correlation was found between 
observed and predicted values. Hence, it was concluded that the evolved 
models may be used for theoretical prediction of responses within the 
factor space. As per the results of the 32 experimental design, the 
optimized formulation of karanj oil emulsion contained 30% w/w of 
karanj oil, 10% w/w/ of Tween 80 and 5% w/w of Span 20.  
 
Microemulsion of karanj oil: 
The microemulsion of karanj oil were prepared using surfactant, 
co-surfactant, solvent, and co-solvent like Cremophor RH 40, Glyceryl 
dilaurate, Tween 80, Ethyl oleate, Transutol P, etc. To optimize the 
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concentration of co-surfactant, surfactant, and solubilizer, a 33 factorial 
design was adopted using the concentration of glyceryl dilaurate  (X1), 
Cremophor RH 40 (X2), and Transutol P (X3) as independent variables at 
three levels: low (-1), medium (0) and high (1). The dependent variables 
were Viscosity (cp), globule size (nm), and Zeta potential (mV). 
 
Response surface curvature can be examined when the variables 
are investigated at three levels. The design provides the following 
emperical second-order equation (Full model, FM): 
 
Y = b0 + b1X1 + b2X2 + b3X3 + b11 X12 + b22 X22 + b33 X32 +b12 X1X2 + 
b23X2X3 + b13X1X3 + b123X1X2X3 
where Y is response, b0 is the intercept, b1, b2 and b3 are regression 
coefficient of main effects and b12, b23, b13 and b123 are regression 
coefficient for the interaction terms. The coefficients with second-order 
terms (b11, b22 and b33) indicate the quadratic nature. Microsoft Excel® 
may be used to identify the non-significant terms. The full and refined 
models (p < 0.05) for Viscosity (cp), globule size (nm), and Zeta potential 
(mV) were obtained.  
 
Desirability function approach was used for solving the multiple 
performance characteristics optimization problems, where all the 
objectives are to attain a definite goal simultaneously. As per the results 
of the 33 experimental design on the basis of overall optimum 
characteristics, the optimized formulation of karanj oil microemulsion 
contained 15%w/w of karanj oil, 12.5% w/w of Glyceryl dilaurate, 22.5% 
w/w/ of Cremophor RH 40, and 10%w/w of Transcutol P. 
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Cream of karanj oil: 
The cream containing karanj oil was prepared by hot emulsification 
method. It contained 30% w/w/ of karanj oil, 5%w/w of stearic Acid, 
10%w/w of ethoxylated cetosteryl alcohol, 5%w/w/ of stearyl alcohol, 
and 10% w/w/ of propylene glycol. 
 
Wound healing activity of Karanj oil Formulations: 
 
Wistar rats of either sex weighing 150-200 gm were used for the 
study. All the animals were maintained under controlled room 
temperature (22±2°C) and relative humidity (50±5%) with 12:00 hr light, 
12:00 hr dark cycle. The animals were housed in colony cages (three 
animals per cage) with free access to diet and water ad libitum during the 
investigation period. All the animals were acclimatized to the laboratory 
environment for 5 days before the experimentation. Six animals (rats) per 
group comprising of three males and three females were used in each 
experiment set. The study protocol was approved by the Institutional 
Animal Ethics Committee (IAEC) of C.U. Shah College of Pharmacy and 
Research, Wadhwan (Gujarat).  
 
Excision wound model was used to evaluate the wound healing 
efficiency. The rats were inflicted with excision wounds by under light 
ether anesthesia. A circular wound of about 300 sq. mm and 2 mm depth 
was made on depilated ethanol sterilized dorsal thoracic region of the 
rats. The animals were divided into seven groups of six each. The animals 
of group I was left untreated and considered as control. The rats of Group 
II were served as reference standard and received 1% w/w framycetin 
 
 
 
                                                                                                    Summary 
139 
sulphate cream (FSC), the animal group III and IV were treated with 
karanj oil and medicated karanj oil, respectively. The animal group V, VI 
and VII were treated with karanj oil emulsion, karanj oil microemulsion 
and karanj oil cream, respectively. The karanj oil or its formulation was 
topically applied once a day, starting from the day of the operation, till 
complete epithelialisation. The parameters studied were wound closure 
and epithelialisation time. The wounds were traced on mm2 graph paper 
on day 0, 4, 8, and 16 and thereafter on alternate days until healing was 
completed. The period of epithelialisation was the number of days 
required for falling of the dead tissue remnants of the wound without any 
residual raw wound 
 
The results of wound healing activity were expressed as mean ± 
standard deviation of six animals in each group. The data were 
statistically evaluated by one-way ANOVA followed by Tukey’s pair-
wise comparison test. The values of p<0.05 were considered as 
statistically significant. The histogram of wound healing activity of 
Karanj oil and its formulations were presented. The results of the wound 
healing activity revealed that the significant promotion of wound healing 
was observed by karanj oil and its formulations as compared to control 
group. 
 
Antimicrobial activity of Karanj oil Formulations: 
 
Karanj oil and its formulations were evaluated for their potential 
antibacterial activity by standard agar well diffusion assay. Petri dishes 
containing agar medium were seeded with microbial suspension of 
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Bacillus subtilis, Staphylococcus aureus, Escherichia coli, and Salmonella 
typhi and media was allowed to solidify. Wells were cut into solidified 
agar media using a sterilized cup-borer. Each sample was poured in the 
respective well and the dishes were incubated at 37 °C for 24 hrs. The 
antibacterial activity was expressed in terms of the mean of diameter of 
zone of inhibition at the end of incubation period. Sterilized distilled 
water was served as negative control. 1% w/w framycetin sulphate cream 
(FSC) ointment diluted and mixed sterilized distilled water was used as 
standard i.e. positive control. 
 
The karanj oil was found to be most inhibitory against S. aureus, 
the least inhibition by karanj oil was found against S. subtilis. The 
medicated karanj oil was found to be most inhibitory against S. aureus, 
the least inhibitory against S. typhi. The results revealed that karanj oil 
and its formulations exhibited significant antibacterial activity. 
 
Hemostatic activity of Karanj oil Formulations: 
 
Rats were slightly ether anesthetized, and abdominal hair was 
carefully removed with electric clipper, they were fasted overnight. The 
animals were divided into six groups of six rats in each. The animals of 
group I was left untreated and considered as control. The rats of Group II, 
III, IV, V, and VI were applied topically karanj oil, medicated karanj oil, 
emulsion, microemulsion, and cream, respectively, on the abdominal area 
gently. Rats were anesthetized by intravenous injection of sodium 
pentobarbital. The caudal caval vein was exposed by a mid-line incision 
and blood was collected at 0 hr and 24 hrs into a plastic syringe 
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containing citrate buffer pH 4.5. The sample was immediately agitated 
and centrifuged in a plastic tube at 1500 rpm for 10 min. Plasma was 
transferred to another plastic tube and the coagulation tests for the 
determination of thromboplastin time (PT), activated partial 
thromboplastin time (APTT) and thrombin time (TT) were performed 
within 3 h. The results of present investigation indicated that the karanj 
oil had shortened the PT, APTT and TT indicating its hemostatic activity. 
 
Conclusions: 
 
The wound healing activity of Karanj oil and its formulations was 
studied by using excision wound model and significant wound healing 
activity was observed. The seed oil of Karanj tree inhibited microbial 
growth of known wound contaminants and accelerated wound healing 
process. It also exhibited hemostatic activity with accelerated blood 
coagulation process. The wound healing, antimicrobial and hemostatic 
activity are interrelated. The results of the present study indicated that 
karanj oil had good potentials for use in wound care and further provided 
a rationale for the use of the plant in wound management in traditional 
medicine practice. 
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